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Abstract Processes that define immunoglobulin repertoires are commonly presumed to be the
same for all murine B cells. However, studies here that couple high-dimensional FACS sorting with
large-scale quantitative IgH deep-sequencing demonstrate that B-1a IgH repertoire differs
dramatically from the follicular and marginal zone B cells repertoires and is defined by distinct
mechanisms. We track B-1a cells from their early appearance in neonatal spleen to their long-term
residence in adult peritoneum and spleen. We show that de novo B-1a IgH rearrangement mainly
occurs during the first few weeks of life, after which their repertoire continues to evolve
profoundly, including convergent selection of certain V(D)J rearrangements encoding specific CDR3
peptides in all adults and progressive introduction of hypermutation and class-switching as animals
age. This V(D)J selection and AID-mediated diversification operate comparably in germ-free and
conventional mice, indicating these unique B-1a repertoire-defining mechanisms are driven by
antigens that are not derived from microbiota.
DOI: 10.7554/eLife.09083.001
Introduction
Follicular B (FOB), marginal zone B (MZB) and B-1a cells are the major mature B cell populations in
the mouse. Although these B cell subsets all produce functionally important antibodies, they differ
profoundly in function and developmental origin (Kantor and Herzenberg, 1993; Hardy and Haya-
kawa, 2001; Baumgarth, 2011). Previous studies have shown that B-1a cells are efficiently gener-
ated during fetal and neonatal life, and are maintained by self-replenishment in adult animals
(Hayakawa et al., 1985; Montecino-Rodriguez et al., 2006; Kantor et al., 1992). In contrast, both
FOB and MZB populations emerge later and are replenished throughout life by de novo develop-
ment from bone marrow (BM) hematopoietic stem cells (HSC). Our recent studies show that BM
HSC reconstitute FOB and MZB, but fail to reconstitute B-1a cells (Ghosn et al., 2012), which are
derived from distinct progenitors at embryonic day 9 yolk sac (Yoshimoto et al., 2011).
For each B cell subset, their antibody responses are enabled by the basic processes that generate
the immunoglobulin (Ig) structure. Multiple mechanisms contribute to creating the primary Ig heavy
(IgH) and light chain (IgL) diversity. For IgH, these include combinatorial assortment of individual var-
iable (V), diversity (D) and joining (J) gene segments, nucleotide(s) trimming in the D-J and V-DJ join-
ing site, and, template-dependent (P-addition) and independent (N-addition) nucleotide(s) insertion
at the joined junctions (Yancopoulos and Alt, 1986; Kirkham and Schroeder, 1994). The V(D)J join-
ing processes define the third IgH complementarity-determining region (CDR3), which often lies at
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the center of antigen binding site and plays a crucial role in defining antibody specificity and affinity
(Xu and Davis, 2000).
After encountering antigen, “‘naı¨ve”’ B cells are activated and can further diversify their primary
antibody repertoire by activation-induced cytidine deaminase (AID)–mediated somatic hypermuta-
tion (SHM), which introduces single or multiple mutations into the IgV regions (Muramatsu et al.,
2000; Wagner and Neuberger, 1996). SHM commonly occurs in germinal centers
(GC) (Victora and Nussenzweig, 2012), where memory B cells expressing high affinity antibodies
are selected (Rajewsky, 1996; Gitlin et al., 2014). Since the antigen-driven SHM-mediated second-
ary Ig diversification is viewed as a crucial adaptation to the environmental needs, the IgH repertoire
(s) expressed by FOB, MZB and B-1a cells from non-immunized animals are thought to be free of
SHM. Our studies here, however, introduce a previously unrecognized SHM mechanism that increas-
ingly diversifies the B-1a pre-immune IgH repertoire as animals age. Importantly, the SHM operates
equally in the presence or absence of microbiota influence.
The B-1a antibody repertoire is commonly thought to be ‘restricted’ with expressing germline
genes, largely because the hybridomas generated from fetal and neonatal B cells, which are mainly
B-1a, have few N-insertions (Carlsson and Holmberg, 1990) and preferentially express the proximal
eLife digest Our immune system protects us by recognizing and destroying invading viruses,
bacteria and other microbes. B cells are immune cells that produce protective proteins called
antibodies to stop infections. These cells are activated by ‘antigens’, which are fragments of
molecules from the microbes or from our own cells. When an antigen binds to a B cell, the cell
matures, multiplies and produces proteins called antibodies. These antibodies can bind to the
antigen, which marks the microbe for attack and removal by other cells in the immune system.
Each antibody consists of two ‘heavy chain’ and two ‘light chain’ proteins. B cells are able to
produce a large variety of different antibodies due to the rearrangement of the gene segments that
encode the heavy and light chains. In mice, there are two kinds of B cells – known as B-1a and B-2
cells – that play different roles in immune responses. B-1a cells have long been known to produce
the ‘natural’ antibodies that are present in the blood prior to an infection. On the other hand, B-2
cells produce antibodies that are specifically stimulated by an infection and are better adapted to
fighting it. Previous studies have shown that both types of antibodies are required to allow animals
to successfully fight the flu virus.
Here, Yang, Wang et al. used a technique called fluorescence-activated cell sorting (or FACS) and
carried out extensive genomic sequencing to study how the B-1a and B-2 populations rearrange
their genes to produce heavy chains. This approach made it possible to separate the different types
of B cells and then sequence the gene for the heavy chain within the individual cells. The
experiments show that the “repertoire” of heavy chains in the antibodies of the B-1a cells is much
less random and more repetitive than that of B-2 populations.
Furthermore, Yang, Wang et al. show that B-1a cells produce and maintain their repertoire of
heavy chains in a different way to other B-2 populations. B-1a cells develop earlier and the major
genetic rearrangements in the gene that encodes the heavy chain occur within the first few weeks of
life. Although the gene rearrangements have mostly stopped by adulthood, the B-1a antibody
repertoire continues to evolve profoundly as the B-1a cells divide over the life of the animal. On the
other hand, the gene rearrangements that make the heavy chains in the B-2 cells continue
throughout the life of the animal to produce the wider repertoire of antibodies found in these cells.
In addition, the processes that continue to change the antibody reperotire in the B-1a cells during
adulthood do not occur in the B-2 populations.
Importantly, the these reperotire-changing processes in B-1a cells also occur in mice that have
been raised in germ-free conditions, which demonstrates that – unlike other B cells – the repertoire
of heavy chains in B-1a cells is not influenced by antigens from microbes. Instead, it is mainly driven
by antigens that are expressed by normal cells in the body. These findings open the way to future
work aimed at understanding how B-1a cells help to protect us against infection, and their role in
autoimmune diseases, where immune cells attack the body’s own healthy cells.
DOI: 10.7554/eLife.09083.002
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7183, Q52 VH family genes (Perlmutter et al., 1985). The N diversity deficit is ascribed to the
absence of expression of terminal deoxynucleotidyl transferase (Tdt), which adds the N nucleotides
to the CDR3 junction (Gilfillan et al., 1993), during fetal life (Feeney, 1990). These early studies left
the impression that the proximal VH gene usage predominates and that there is little N-addition in
the B-1a IgH repertoire.
Later studies by the Rajewsky group, however, showed that although neonatal (4 day) splenic B-
1a cells contain very few N-insertions, N addition is readily detected in substantial numbers of peri-
toneal B-1a cells from adult animals (Gu et al., 1990), indicating that B-1a cells are continuously gen-
erated after Tdt is expressed. Holmberg lab similarly found the low N-region diversity in the adult
Figure 1. The B-1a IgH CDR3 sequences are much less diverse and recur more frequently than the CDR3
sequences expressed by FOB and MZB B subsets. IgH CDR3 tree-map plots illustrating the IgH CDR3 nucleotide
sequences expressed by indicated B cell subsets sorted from one 2-month old C57Bl/6 mouse. Each rectangle in a
given tree-map represents a unique CDR3 nucleotide sequence and the size of each rectangle denotes the
relative frequency of an individual sequence. The colors for the individual CDR3 sequences in each tree-map plot
are chosen randomly thus do not match between plots. The numbers shown in the CDR3 tree-map plots highlight
the highly reoccurring CDR3 sequences including PtC-binding CDR3 sequences. 1, ARFYYYGSSYAMDY, V1-55D1-
1J4; 2, MRYGNYWYFDV, V11-2D2-8J1; 3, MRYSNYWYFDV, V11-2D2-6J1; 4, MRYGSSYWYFDV, V11-2D1-1J1. Lower
middle panel: FACS plots showing the gating strategy used to sort the phenotypically defined each B cell subset
from spleen (s) or peritoneal cavity (p). Note: peritoneal B-1a cells are well known to express CD11b, a marker
expressed on many myeloid cells including macrophage and neutrophils. The level of CD11b expressed on
peritoneal B-1a cells, however, is roughly 100 fold lower than the level of CD11b expressed on the myeloid cells.
This drastic difference is sufficient to separate the CD11b+ B-1a cells from the myeloid cells if monoclonal anti-
CD11b reagent is included in the dump channel (Figure 1—figure supplement 3).
DOI: 10.7554/eLife.09083.003
The following figure supplements are available for figure 1:
Figure supplement 1. FACS plots showing CD43+ CD5+ IgM+ B-1a cells in E19 fetal liver.
DOI: 10.7554/eLife.09083.004
Figure supplement 2. Recurrent VH11-encoded PtC-binding V(D)J sequences.
DOI: 10.7554/eLife.09083.005
Figure supplement 3. CD11b expression on peritoneal B-1a (CD5+) and B-1b (CD5-) is roughly 100-fold lower
than the CD11b expression on myeloid cells.
DOI: 10.7554/eLife.09083.006
Yang et al. eLife 2015;4:e09083. DOI: 10.7554/eLife.09083 3 of 32
Research article Cell biology Immunology
T
a
b
le
1
.
S
u
m
m
a
ry
o
f
th
e
se
q
u
e
n
ce
s
fo
r
6
0
se
p
a
ra
te
ly
so
rt
e
d
B
ce
ll
p
o
p
u
la
ti
o
n
s
a
n
a
ly
ze
d
in
th
is
st
u
d
y.
S
a
m
p
le
Id
S
u
b
se
t
S
tr
a
in
A
g
e
C
o
n
d
it
io
n
M
ic
e
R
N
T
*
R
N
U
*
R
P
U
*
C
N
T
*
C
N
U
*
C
P
U
*
1
7
6
3
1
F
O
B
W
T
2
M
S
P
F
si
n
g
le
1
0
0
6
0
3
0
1
5
1
2
1
0
6
5
8
7
1
9
0
3
4
0
0
2
1
2
4
0
2
0
4
7
0
2
1
3
9
6
6
F
O
B
W
T
3
.5
M
S
P
F
si
n
g
le
1
5
0
8
1
2
3
1
0
0
3
2
4
8
0
1
1
3
0
6
5
2
1
4
9
1
1
1
4
6
7
8
3
8
7
0
6
F
O
B
W
T
4
M
S
P
F
si
n
g
le
1
8
0
3
6
5
5
3
5
7
7
2
7
8
1
7
1
5
9
7
1
0
1
6
9
0
1
1
6
5
6
8
4
8
7
0
2
F
O
B
W
T
5
M
S
P
F
si
n
g
le
1
5
6
6
8
1
5
4
1
9
5
2
7
7
2
8
1
3
6
1
0
1
1
6
9
5
1
1
6
6
4
9
5
1
3
9
6
7
F
O
B
A
ID
K
O
5
M
S
P
F
si
n
g
le
3
5
9
6
7
1
4
6
2
3
1
3
2
0
3
2
7
7
2
6
7
1
8
7
7
1
3
3
6
1
1
1
6
1
M
Z
B
W
T
1
M
S
P
F
si
n
g
le
3
3
5
4
8
1
9
6
2
8
1
2
7
4
4
2
5
6
7
4
6
5
8
4
6
4
7
1
7
1
0
6
5
8
M
Z
B
W
T
2
M
S
P
F
si
n
g
le
7
1
4
5
8
2
6
9
7
8
1
8
2
7
8
6
1
2
5
8
1
1
5
1
2
1
1
1
7
0
8
7
6
3
0
M
Z
B
W
T
2
M
S
P
F
si
n
g
le
1
0
3
2
3
8
1
1
3
9
8
3
2
6
2
5
2
0
9
3
2
3
5
3
2
0
7
8
0
1
9
7
9
2
9
8
7
0
1
M
Z
B
W
T
4
M
S
P
F
si
n
g
le
2
1
4
2
3
8
5
5
0
7
5
2
6
4
5
8
1
9
1
0
6
5
1
5
4
6
1
1
5
0
2
1
1
0
8
7
0
0
M
Z
B
W
T
5
M
S
P
F
si
n
g
le
1
1
8
8
6
3
4
2
3
1
0
2
2
7
9
4
1
0
2
8
9
4
1
4
5
1
7
1
4
1
8
0
1
1
1
3
3
3
8
M
Z
B
W
T
4
M
G
F
si
n
g
le
1
6
2
7
5
4
3
9
9
3
0
2
3
6
1
1
1
4
1
6
4
6
1
2
9
3
9
1
2
6
0
5
1
2
1
3
3
4
3
M
Z
B
W
T
4
M
G
F
si
n
g
le
5
9
5
7
8
0
8
5
4
9
7
4
5
8
2
0
5
3
6
0
7
2
1
9
2
6
6
1
8
4
8
0
1
3
1
1
1
6
3
p
B
-1
a
W
T
1
M
S
P
F
p
o
o
l
o
f
3
m
ic
e
4
5
8
8
2
1
1
2
9
0
5
5
9
6
4
1
3
6
8
3
2
3
7
3
0
0
7
1
4
1
0
6
6
0
p
B
-1
a
W
T
2
M
S
P
F
si
n
g
le
2
2
2
3
2
4
1
7
3
1
1
8
6
3
0
2
0
7
7
4
9
3
8
9
1
3
6
4
9
1
5
1
3
0
1
8
p
B
-1
a
W
T
2
M
S
P
F
si
n
g
le
8
0
8
8
7
9
3
6
0
3
1
1
4
8
1
7
7
5
3
8
6
8
4
7
6
9
4
3
7
4
1
6
7
6
2
8
p
B
-1
a
W
T
2
M
S
P
F
si
n
g
le
1
7
8
4
6
7
7
5
9
4
5
8
2
2
1
0
5
1
7
0
6
2
3
5
6
6
0
1
5
8
4
8
1
7
1
1
1
6
0
p
B
-1
a
W
T
2
W
S
P
F
p
o
o
l
o
f
8
m
ic
e
6
5
3
1
7
1
4
7
0
0
7
0
2
5
5
8
0
3
4
4
2
4
0
3
7
0
4
1
8
1
0
6
5
5
p
B
-1
a
W
T
3
W
S
P
F
p
o
o
l
o
f
5
m
ic
e
6
2
8
7
5
1
2
1
6
2
6
6
2
2
5
7
5
5
8
4
1
8
0
3
6
9
4
1
9
8
7
0
5
p
B
-1
a
W
T
4
M
S
P
F
si
n
g
le
3
1
0
0
7
7
2
8
4
4
1
1
1
8
8
6
2
8
7
6
9
5
5
0
6
3
4
7
0
7
2
0
9
8
7
0
p
B
-1
a
W
T
4
M
S
P
F
si
n
g
le
2
2
9
1
0
0
2
6
2
9
9
1
0
4
6
9
2
1
1
5
1
4
4
7
4
5
4
4
8
0
2
1
1
1
1
6
5
p
B
-1
a
W
T
5
M
S
P
F
si
n
g
le
1
0
5
4
1
0
1
9
5
2
8
8
9
2
6
9
5
9
9
4
4
4
3
5
4
1
6
2
2
2
8
7
0
7
p
B
-1
a
W
T
5
M
S
P
F
si
n
g
le
3
2
0
2
5
2
2
9
7
8
6
1
2
4
2
3
2
9
6
9
4
6
4
7
2
2
4
3
8
4
2
3
9
8
6
1
p
B
-1
a
W
T
6
M
S
P
F
si
n
g
le
2
6
6
1
3
5
6
8
3
3
2
3
5
2
3
5
4
2
1
5
2
1
1
4
6
1
2
4
8
7
0
4
p
B
-1
a
A
ID
K
O
4
M
S
P
F
si
n
g
le
2
6
4
3
4
0
3
3
7
4
5
1
4
5
1
9
2
4
5
9
4
1
6
6
4
8
6
2
9
4
2
5
1
0
6
5
7
p
B
-2
W
T
2
M
S
P
F
si
n
g
le
5
3
9
5
3
2
3
0
5
9
1
6
8
8
3
4
4
9
8
6
1
0
0
8
4
9
9
2
3
2
6
7
6
2
9
p
B
-2
W
T
2
M
S
P
F
si
n
g
le
1
3
1
5
6
6
3
1
2
3
4
7
2
4
7
3
3
7
1
2
3
8
2
2
5
1
6
9
2
5
1
6
0
6
5
2
7
1
3
9
6
9
p
B
-2
W
T
3
.5
M
S
P
F
si
n
g
le
1
8
6
8
1
7
2
4
3
0
4
1
7
6
8
9
1
7
0
7
6
8
9
0
8
9
8
9
2
5
2
8
9
8
6
2
p
B
-2
W
T
4
M
S
P
F
si
n
g
le
2
2
5
9
1
1
3
3
7
7
8
7
3
7
1
7
3
4
3
4
3
8
2
4
3
5
7
2
9
1
3
9
7
3
p
B
-2
A
ID
K
O
5
M
S
P
F
si
n
g
le
6
1
7
8
9
3
6
2
3
1
9
4
1
1
6
5
5
6
6
8
2
6
1
7
5
3
6
1
6
9
6
5
3
0
1
3
0
0
0
sB
-1
a
W
T
2
d
S
P
F
p
o
o
l
o
f
8
m
ic
e
2
9
4
3
9
9
5
4
2
4
9
2
5
2
5
3
6
9
3
1
4
8
2
7
5
8
3
1
1
0
6
5
1
sB
-1
a
W
T
5
d
S
P
F
si
n
g
le
1
2
3
3
6
0
2
2
4
7
2
1
0
8
3
8
1
1
3
1
6
1
7
4
5
3
5
9
7
6
3
2
1
0
6
5
9
sB
-1
a
W
T
5
d
S
P
F
si
n
g
le
2
1
0
0
5
5
2
8
1
4
0
1
2
4
1
1
1
9
2
6
6
2
7
3
0
7
5
8
1
2
3
3
9
8
6
6
sB
-1
a
W
T
5
d
S
P
F
si
n
g
le
5
2
9
8
6
1
5
6
0
0
6
8
6
4
4
6
5
8
0
4
5
9
5
3
8
3
7
3
4
1
0
6
5
2
sB
-1
a
W
T
6
d
S
P
F
si
n
g
le
1
7
2
8
7
5
2
6
4
3
7
1
2
5
4
5
1
5
9
3
0
4
7
6
8
3
6
3
6
5
3
5
9
8
6
5
sB
-1
a
W
T
7
d
S
P
F
si
n
g
le
7
1
3
0
9
1
8
4
4
6
8
7
7
5
6
4
2
4
1
5
4
8
2
4
9
4
1
3
6
9
8
6
8
sB
-1
a
W
T
7
d
S
P
F
si
n
g
le
2
0
1
8
1
3
3
5
0
6
9
1
4
4
7
3
1
8
6
2
2
7
7
8
4
7
6
8
4
3
T
a
b
le
1
co
n
ti
n
u
e
d
o
n
n
e
xt
p
a
g
e
Yang et al. eLife 2015;4:e09083. DOI: 10.7554/eLife.09083 4 of 32
Research article Cell biology Immunology
T
a
b
le
1
co
n
ti
n
u
e
d
S
a
m
p
le
Id
S
u
b
se
t
S
tr
a
in
A
g
e
C
o
n
d
it
io
n
M
ic
e
R
N
T
*
R
N
U
*
R
P
U
*
C
N
T
*
C
N
U
*
C
P
U
*
3
7
1
0
6
5
6
sB
-1
a
W
T
2
M
S
P
F
si
n
g
le
3
6
9
7
3
2
3
9
6
0
3
1
9
7
5
9
3
4
2
9
1
4
9
4
8
9
9
0
4
8
3
8
1
3
0
0
4
sB
-1
a
W
T
2
M
S
P
F
si
n
g
le
1
8
5
9
4
8
2
7
9
5
2
1
3
8
7
5
1
6
8
5
2
2
7
3
1
3
7
0
2
2
3
9
7
6
3
2
sB
-1
a
W
T
2
M
S
P
F
si
n
g
le
1
8
2
5
2
1
8
1
0
2
7
9
7
4
3
1
9
0
1
7
1
9
2
4
6
1
2
4
2
8
1
1
1
4
4
4
0
1
1
1
6
8
sB
-1
a
W
T
2
W
S
P
F
si
n
g
le
5
3
6
6
0
3
7
0
2
0
1
2
8
8
2
9
4
9
6
6
7
1
1
1
9
4
8
1
0
9
1
3
4
1
1
3
0
0
5
sB
-1
a
W
T
2
W
S
P
F
si
n
g
le
9
8
0
1
7
2
8
3
3
1
1
5
0
0
1
8
5
4
8
9
8
8
2
0
8
2
0
7
4
2
1
0
6
5
4
sB
-1
a
W
T
3
W
S
P
F
si
n
g
le
1
4
6
5
6
0
3
3
8
1
4
1
9
6
9
7
1
3
1
0
9
1
1
1
9
9
5
1
1
4
5
1
4
3
1
3
9
7
0
sB
-1
a
W
T
3
.5
M
S
P
F
si
n
g
le
1
7
0
9
2
5
1
3
8
0
9
9
2
8
9
1
6
0
4
8
0
4
5
1
3
4
2
7
3
4
4
1
3
3
3
5
sB
-1
a
W
T
4
M
S
P
F
si
n
g
le
2
2
1
7
5
4
8
2
2
3
4
4
9
1
8
6
8
3
1
1
3
1
1
0
9
0
4
5
1
3
3
4
2
sB
-1
a
W
T
4
M
S
P
F
si
n
g
le
2
8
3
0
7
2
2
3
6
6
8
1
2
9
4
7
2
6
2
7
4
4
5
3
5
7
5
0
3
2
4
6
8
6
9
9
sB
-1
a
W
T
4
M
S
P
F
si
n
g
le
1
4
2
8
3
8
1
9
1
5
1
9
9
3
8
1
3
0
9
1
5
4
3
7
0
4
0
8
6
4
7
9
8
6
3
sB
-1
a
W
T
4
M
S
P
F
si
n
g
le
7
3
6
7
6
1
6
5
9
9
8
7
1
3
6
5
5
7
1
4
2
3
3
4
0
9
2
4
8
1
1
1
6
7
sB
-1
a
W
T
5
M
S
P
F
si
n
g
le
5
0
1
3
6
7
3
8
9
1
2
1
7
3
3
6
4
6
3
8
6
3
7
5
7
3
7
1
6
3
4
9
8
7
0
8
sB
-1
a
W
T
5
M
S
P
F
si
n
g
le
5
7
7
1
1
4
5
2
7
2
3
2
2
2
7
2
5
3
1
5
0
8
9
1
4
6
8
4
4
1
5
0
9
8
6
7
sB
-1
a
W
T
6
M
S
P
F
si
n
g
le
1
1
3
4
9
2
2
0
6
1
2
1
0
6
2
5
1
0
1
7
9
1
4
5
6
3
4
3
4
3
5
1
1
3
9
6
5
sB
-1
a
A
ID
K
O
4
M
S
P
F
si
n
g
le
1
7
7
7
8
2
1
6
4
1
9
1
2
2
8
1
1
6
4
1
8
9
6
5
3
9
6
2
9
3
5
2
1
3
9
7
1
sB
-1
a
A
ID
K
O
4
M
S
P
F
si
n
g
le
5
1
7
1
4
1
3
4
1
5
9
2
2
0
3
1
4
8
2
5
4
3
8
9
6
6
8
3
9
5
5
3
1
3
9
6
8
sB
-1
a
A
ID
K
O
5
M
S
P
F
si
n
g
le
4
2
7
6
7
1
3
0
8
3
9
2
0
5
1
0
3
9
6
9
7
4
9
1
6
2
8
5
4
5
5
4
1
3
9
7
2
sB
-1
a
A
ID
K
O
5
M
S
P
F
si
n
g
le
7
0
6
1
1
6
3
6
2
1
7
2
3
2
5
5
6
6
0
8
7
4
9
2
9
4
8
7
4
4
5
5
1
3
0
0
1
sB
-1
a
W
T
4
M
G
F
si
n
g
le
4
3
5
0
7
8
7
3
4
4
8
5
5
3
8
9
4
7
2
3
1
8
2
2
4
9
5
6
1
3
0
0
2
sB
-1
a
W
T
4
M
G
F
si
n
g
le
4
7
2
0
3
8
6
8
3
4
8
2
0
4
2
2
7
9
2
0
5
3
1
9
6
5
5
7
1
3
0
0
3
sB
-1
a
W
T
4
M
G
F
si
n
g
le
2
1
3
3
4
7
2
2
2
4
6
1
1
0
6
8
1
9
7
7
6
9
4
7
0
5
4
4
4
9
5
8
1
3
0
1
7
sB
-1
a
W
T
4
M
G
F
si
n
g
le
5
3
2
2
5
0
4
0
4
9
7
1
7
3
7
5
5
0
1
9
0
8
7
0
1
9
6
3
9
8
5
9
1
3
3
3
7
sB
-1
a
W
T
4
M
G
F
si
n
g
le
2
8
5
5
9
6
3
2
2
4
4
1
7
2
4
0
4
7
1
5
4
4
1
4
8
6
6
0
1
3
3
4
1
sB
-1
a
W
T
4
M
G
F
si
n
g
le
3
8
8
2
0
8
2
8
9
4
2
1
4
8
3
7
3
6
0
7
2
7
5
6
7
4
5
1
4
4
Id
is
a
u
n
iq
u
e
id
e
n
ti
fi
e
r
fo
r
th
e
se
q
u
e
n
ce
ru
n
R
N
T
*,
to
ta
l
ra
w
n
u
cl
e
o
ti
d
e
se
q
u
e
n
ce
s
R
N
U
*,
u
n
iq
u
e
ra
w
n
u
cl
e
o
ti
d
e
se
q
u
e
n
ce
s
R
P
U
*,
u
n
iq
u
e
ra
w
p
e
p
ti
d
e
se
q
u
e
n
ce
s
C
N
T
*,
to
ta
l
cl
e
a
n
n
u
cl
e
o
ti
d
e
se
q
u
e
n
ce
s
C
N
U
*,
u
n
iq
u
e
cl
e
a
n
n
u
cl
e
o
ti
d
e
se
q
u
e
n
ce
s
C
P
U
*,
u
n
iq
u
e
cl
e
a
n
p
e
p
ti
d
e
se
q
u
e
n
ce
s
S
e
q
u
e
n
ce
st
a
ti
st
ic
s
R
N
T
*
R
N
U
*
R
P
U
*
C
N
T
*
C
N
U
*
C
P
U
*
T
o
ta
l
1
.9
E
+
0
7
2
.1
E
+
0
6
1
.1
E
+
0
6
1
.8
E
+
0
7
4
.9
E
+
0
5
4
.7
E
+
0
5
M
e
a
n
3
1
9
8
6
5
3
5
6
1
0
1
7
8
4
8
2
9
5
1
7
4
8
2
3
3
7
7
6
2
%
C
V
1
2
2
8
6
7
4
1
2
5
6
1
6
3
D
O
I:
1
0
.7
5
5
4
/e
Li
fe
.0
9
0
8
3
.0
0
7
Yang et al. eLife 2015;4:e09083. DOI: 10.7554/eLife.09083 5 of 32
Research article Cell biology Immunology
peritoneal B-1a repertoire (Tornberg and Holmberg, 1995). Our early studies confirm and extend
these findings by showing that roughly two thirds of the IgH sequences from individually sorted peri-
toneal B-1a cells have N additions (Kantor et al. 1997). Furthermore, recent studies have shown
that B-1a progenitors from both fetal liver and adult BM sources generate peritoneal B-1a cells with
substantial N-addition (Holodick et al., 2014). Collectively, these findings demonstrate that the peri-
toneal B-1a IgH repertoire diversity is greater than previously thought.
However, these studies mainly characterized the repertories of B cells in the peritoneal cavity
(PerC) and leave the questions open as to whether and how the repertoire changes throughout
ontogeny in B cells at various sites of development and function. Studies here address these issues.
We show that the B-1a IgH repertoire differs drastically from the repertories expressed by splenic
FOB, MZB and peritoneal B-2 cells. In addition, we track the development of B-1a cells from their
early appearance in neonatal spleen to their long-term residence in adult peritoneum and spleen,
and elucidate the previous unrecognized somatic mechanisms that select and diversify the B-1a IgH
repertoire over time. Most importantly, the potent mechanisms that uniquely act in B-1a (not in FOB
and MZB cells) operate comparably in germ-free (GF) and conventional mice reared under specific
pathogen free (SPF) condition, indicating that these repertoire-defining mechanisms are not driven
by microbiota-derived antigens.
The dearth of these advanced understandings in the previous studies is largely due to technical
difficulties that limited both their scope and depth. Studies analyzing Ig sequences from immortal-
ized cell lines (e.g., hybridomas) or LPS-stimulated B cells had obvious sampling biases. In addition,
earlier studies mainly focused on particular VH families (e.g., J558, 7183), even though the mouse
IgH locus contains over 100 functional VH genes (Kirkham and Schroeder, 1994). The introduction
of single cell analyses enabled higher precision and lower bias than the bulk measurements. How-
ever, they were constrained profoundly by sequencing costs and technical challenges. Indeed, our
previous single cell analysis reported only 184 IgH sequences derived from 85% recovered sorted
single cells representative of three types of peritoneal B subsets (Kantor et al., 1997). Thus, while
the data yielded key insights, hundreds or thousands of single cells would need to be analyzed to
obtain a more comprehensive view for a single B subset repertoire. Finally, difficulties in defining
and cleanly sorting rare B subsets (e.g., splenic B-1a) further compromise the attempt to develop a
thorough view of repertoire(s) expressed by various B cell subsets at the different anatomic location
and ontogenic stage.
To overcome these obstacles, we have coupled high-dimensional (Hi-D) FACS sorting with unique
IgH multiplex PCR technologies, which allow inclusive amplification of IgH transcripts for each sorted
B subset and ultimate sequencing of these sequences. Using barcoded sample multiplexing, we
have performed a large-scale quantitative and comparative study of the ‘pre-immune’ IgH reper-
toires expressed by various functionally and developmentally distinct mature B subsets (splenic FOB,
MZB and B-1a; peritoneal B-2 and B-1a) from non-immune C57BL/6J mice. In addition, since micro-
biota are often thought to influence the Ig repertoire, we have compared the B-1a IgH repertoires in
GF or conventional mice.
Results
The B-1a pre-immune IgH repertoire is far more restricted and
repetitive than the repertoire expressed by FOB and MZB subsets
We sorted splenic and peritoneal B-1a (dump- CD19+ CD93-IgMhi IgDlo/- CD21-/lo CD23- CD43+
CD5+); splenic FOB and peritoneal B-2 (dump- CD19+ CD93- IgMlo IgDhi CD23+ CD43- CD5-); and
splenic MZB (dump- CD19+ CD93- IgMhi IgDlo/- CD21hi CD23lo/- CD43- CD5-) from non-immune
C57BL/6 mice (Figure 1). We generated and amplified IgH cDNA libraries from each subset. We
then pooled the libraries, which are distinguishable by barcode, and sequenced them (Illumina
MiSeq). In all, we sequenced 60 separately prepared libraries, each derived from 1-2 x104 B cells of
a given subset sorted from mice at the same or different ages (from 2 days to 6 months, > 30 mice)
(Table 1). Overall 18 million total clean nucleotide sequences (CNT) and about half million unique
clean nucleotide sequences (CNU) were analyzed in the study (Table 1).
We also attempted to analyze the B-1a repertoire in fetal liver but found that there were too few
B-1a cells to reliably sequence with our method. In essence, FACS analysis of embryonic day 19
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(E19) fetal liver cells shows that IgM+ B cells represent only 0.6% of CD19+ total B cells and that
only around 20% of these IgM+ B cells express the B-1a CD43+ CD5+ phenotype (Figure 1—figure
supplement 1). The frequencies of IgM+ B cell in E18 fetal liver are even lower (0.2% of CD19+ B
cells). These numbers are too low for us to recover enough material for sequencing from a feasible
number of embryos.
The IgH CDR3 tree maps for each B cell subset show that splenic FOB and peritoneal B-2 cells
express highly diversified IgH CDR3 nucleotide sequences, as do MZB cells (Figure 1). In contrast,
CDR3 nucleotide sequences expressed by B-1a cells from either spleen or PerC are far less diverse
and recur much more frequently (Figure 1). The recurrent CDR3 sequences include the well-studied
VH11-encoded sequences specific for phosphatidylcholine (PtC) (Figure 1—figure supplement 2)
and known to occur frequently in B-1a cells (Mercolino et al., 1988; Hardy et al., 1989; Seidl et al.,
1997).
D50 metric analysis quantifying the IgH CDR3 nucleotide sequence diversity shows that the IgH
CDR3 nucleotide sequences expressed by the FOB and MZB subsets are significantly more diverse
than those expressed by splenic and peritoneal B-1a cells (p = 0.0002, Mann-Whitney-Wilcoxon
Test) (Figure 2A). Consistent with this finding, IgH CDR3 peptide pairwise sharing analysis, which
measures the similarity of IgH CDR3 peptide expression for each B cell subset sorted from different
mice, shows that the same CDR3 peptide sequences frequently appear in both splenic and perito-
neal B-1a cells from different mice whereas the common CDR3 peptides are rare in FOB and MZB
subsets (Figure 2B). Taken together, these data demonstrate that the B-1a pre-immune IgH reper-
toire is far more restricted and repetitive than IgH repertoires expressed by FOB and MZB subsets.
Figure 2. The B-1a pre-immune IgH repertoire is far more restricted than the pre-immune IgH repertoires
expressed by splenic FOB, MZB and peritoneal B-2 cells. (A) D50 metric analysis quantifying the IgH CDR3
diversity for B cell subsets from mice at the indicated age. Low D50 values are associated with less diversity. Each
dot represents the data for a B cell sample from an individual mouse except for the 2 day splenic B-1a data, which
are derived from sorted cells pooled from 8 mice. B-1a samples are labeled with red; B-2 samples include FOB
(green, n = 4), pB-2 (purple, n = 4) and MZB (yellow, n = 4). The data for germ-free (GF) animals is discussed at the
end of the Result section. (B) CDR3 peptide pair-wise sharing analysis of IgH repertoire similarity among multiple
samples for each B cell group (n = 5-9). Each dot represents the percentage of common CDR3 peptides in one
sample that are also found in another sample within a given group. For example, to compute the similarity
between sample A and B, the percentage of CDR3 peptides in sample A that are also found in sample B (pA ! B ),
together with the percentage of CDR3s in sample B that are also in sample A (pB!A) are used as an indicator. For
comparison of 6 splenic B-1a samples in 5-7 day group, there are 30 comparisons. Right upper: p values showing
the statistical significance between two groups. Box plots represent the 10th, 25th, 50th, 75th and 90th percentiles
here and in other figures.
DOI: 10.7554/eLife.09083.008
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Table 2. Top 10 highly recurring CDR3 sequences (peptide and V(D)J recombination) detected in
each of the listed splenic B-1a samples.
sB-1a samples Top 10 IgH CDR3 sequences
Id Age Peptide V(D)J
11168 2 weeks 1 ANDY V1-53 J2
2 AKHGYDAMDY V2-9 D2-9 J4
3 ARRYYGSSYWYFDV V1-55 D1-1 J1
4 ANWDY V1-53 D4-1 J2
5 MRYSNYWYFDV V11-2 D2-6 J1
6 ARDAYYWYFDV V7-1 J1
7 ATDYYAMDY V1-26 J4
8 ARFYYYGSSYAMDY V1-55 D1-1 J4
9 AIYYLDY V1-53 D2-8 J2
10 ARHYGSSYWYFDV V2-6-2 D1-1 J1
10654 3 weeks 1 ARRYYGSSYWYFDV V1-55 D1-1 J1
2 ARSYSNYVMDY V1-76 D2-6 J4
3 ARYYGSNYFDY V7-3 D1-1 J2
4 ARGASYYSNWFAY V1-55 D2-6 J3
5 ALTGTAY V1-53 D4-1 J3
6 ARAGAGWYFDV V5-9 D4-1 J1
7 TYSNY V6-6 D2-6 J2
8 ARTGTYYFDY V1-53 D4-1 J2
9 AMVDY V1-64 D2-9 J2
10 ARWGTTVVGY V1-7 D1-1 J2
7632 2 months 1 MRYGNYWYFDV V11-2 D2-8 J1
2 MRYSNYWYFDV V11-2 D2-6 J1
3 MRYGSSYWYFDV V11-2 D1-1 J1
4 ATFSY V1-55 J2
5 ARFYYYGSSYAMDY V1-55 D1-1 J4
6 ARIPNWVWYFDV V1-55 D4-1 J1
7 ARWDTTVVAPYYFDY V1-7 D1-1 J2
8 ARDYYGSSWYFDV V1-26 D1-1 J1
9 TYYDYDLYAMDY V14-4 D2-4 J4
10 ARFITTVVATRYWYFDV V1-9 D1-1 J1
8699 4 months 1 ARSADYGGYFDV V1-64 D2-4 J1
2 ARGAY V1-80 J2
3 ARSYYDYPWFAY V1-76 D2-4 J3
4 ARRWLLNAMDY V1-9 D2-9 J4
5 ARPYYYGSSPWFAY V1-69 D1-1 J3
6 ARNDYPYWYFDV V1-4 D2-4 J1
7 ARSGDY V1-64 J2
8 ARVIGDY V1-53 D2-14 J4
9 ARANY V1-55 J3
10 AVNWDYAMDY V1-84 D4-1 J4
Table 2 continued on next page
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VH gene usage differs among the B-1a, FOB and MZB pre-immune IgH
repertoires
We quantified the frequency of IgH sequences expressing individual VH gene for each sorted B cell
sample and then compared the VH gene usage between two B cell subsets. B-1a cells are well-known
to undergo self-replenishing in adult (Kantor et al., 1995). To minimize the impact of clonal expan-
sion on the VH gene usage profile, we collected normalized data, in which we scored each distinct
IgH CDR3 nucleotide sequence expressing a given VH gene as one, no matter how many times this
sequence was detected.
Our approach enables detection of Ig transcripts expressing about 100 different VH genes that
belong to 14 VH families (Figure 3). B-1a cells express all of these detected VH genes (Figure 3A),
contrasting with earlier impressions, based largely on hybridomas sequences from fetal and neonatal
mice (Malynn et al., 1990), that VH usage in the B-1a repertoire is very restricted. However, despite
the broad VH usage, certain VH genes, notably V10-1 (DNA4), V6-6 (J606), V11-2 (VH11) and V2-6-8
(Q52), are expressed at a significantly higher frequency in splenic B-1a than MZB cells (p<0.05,
Welch’s t-test, Figure 3B).
Similar to MZB cells, splenic FOB and peritoneal B-2 cells show lower frequency in expressing
these B-1a favored VH genes, i.e., V6-6 (J606), V11-2 (VH11) and V2-6-8 (Q52) (Figure 3—figure sup-
plement 1B–C). Conversely, these B subsets tend to preferentially use the largest VH family, V1
(J558), located distal to DH and JH gene segments (Yancopoulos and Alt, 1986). MZB cells, in par-
ticular, have a higher tendency to express certain V1 (J558) family genes including V1-82, V1-72, V1-
71, V1-42, V1-18 and V1-5 (Figure 3B).
The VH usage in the peritoneal B-1a cells is further biased toward V6-6 (J606), V9-3 (Vgam3.8),
V2-9 (Q52) and V2-6-8 (Q52) genes, which are already favored in the splenic B-1a cells (Figure 3—
Table 2 continued
sB-1a samples Top 10 IgH CDR3 sequences
Id Age Peptide V(D)J
8708 5 months 1 ASLTY V1-55 J2
2 TCNYH V14-4 D2-8 J4
3 LIGRNY V1-55 D2-14 J2
4 MRYSNYWYFDV V11-2 D2-6 J1
5 AKQPYYGSSYWYFDV V2-3 D1-1 J1
6 AGSSYAYYFDY V1-66 D1-1 J2
7 ARRGIDLLWYHYYAMDY V1-26 D2-8 J4
8 ARKSSGSRAMDY V7-3 D3-2 J4
9 ASYAMDY V7-3 J4
10 ARLYYGNSYWYFDV V1-55 D2-8 J1
9867 6 months 1 ARKYYPSWYFDV V1-55 D1-1 J1
2 AREGGKFY V1-7 J2
3 AKSSGYAMDY V1-55 D3-2 J4
4 ARWVITTVARYFDV V1-85 D1-1 J1
5 ARGFY V1-80 J2
6 AKEGGYYVRAMDY V1-55 D1-2 J4
7 ARSMDY V1-80 J4
8 ASAMDY V1-64 J4
9 TKGGYHDYDDGAWFVY V1-53 D2-4 J3
10 ARKFYPSWYFDV V1-55 J3
Table lists the top 10 highly recurring CDR3 sequences (peptide and V(D)J recombination) shown in the individual
CDR3 tree-map plot of the splenic B-1a samples from 2 week to 6 month old mice (Figure 5A). For each splenic
B-1a sample, the Id number and mouse age are shown in column 1 and column 2 respectively.
DOI: 10.7554/eLife.09083.015
Yang et al. eLife 2015;4:e09083. DOI: 10.7554/eLife.09083 9 of 32
Research article Cell biology Immunology
figure supplement 1A). This finding indicates that the splenic and peritoneal B-1a populations are
not in equilibrium and the latter is further enriched for cells expressing certain VH genes.
The B-1a IgH repertoire integrates rearrangements from de novo B-1a
development that occur mainly during the first few weeks of life
Unlike FOB and MZB subsets, de novo B-1a development initiates prior to birth and decreases to a
minimum in adult animals (Lalor et al., 1989; Barber et al., 2011). B-1a cells persist thereafter as a
self-replenishing population (Kantor et al., 1995). To minimize the impact of self-replenishment on
the N-addition distribution profile, and hence to weight the repertoire for de novo generated
IgH sequences for B-1a cells, we collected normalized data that counts each distinct IgH sequence
containing indicated N nucleotide insertions as a single sequence, regardless how many times this
sequence was detected.
Consistent with Tdt expression, which is absent during the fetal life and initiates shortly after birth
(Feeney, 1990; Bogue et al., 1992), N nucleotide insertion analysis of the splenic B-1a IgH reper-
toires demonstrate that roughly 60% of IgH sequences expressed by splenic B-1a cells from 2-–6
day mice do not contain N insertions at IgH CDR3 junction (D-J and V-DJ); about 30% contain 1–2
insertions; and, <15% contain 3–4 N-nucleotide insertions (Figure 4A,B). After 6 days, however, the
frequency of sequences containing >3 N-additions progressively increases until the animals are
weaned (roughly 3 weeks) (Figure 4A,B). After weaning, the N-addition pattern stabilizes, i.e., about
50% IgH sequences contain 3–7 N nucleotide insertions and about 30% have more than 8 N nucleo-
tide insertions at IgH CDR3 junctions, and remains stable at this level for at least 5 months
(Figure 4A,B).
In essence, splenic B-1a cells from 2-6 day mice largely originate from fetal and early neonatal
wave(s) of B-1a development when Tdt is poorly expressed. As newborns progress to maturity, B-1a
cells, which are originated in the earlier wave(s), are ‘diluted’ by B-1a cells that emerge during later
development. The high frequency of N nucleotide additions in the adult splenic B-1a IgH repertoire
indicates that a higher proportion of B-1a cells are actually generated postnatally after Tdt is
expressed.
Cohering with the increased N diversity in the adulthood, CDR3 peptide pairwise sharing analysis
shows that the expression of common IgH CDR3 peptides is significantly more frequent in neonatal
splenic B-1a cells than in adult splenic B-1a cells (p<2e-16, Mann-Whitney-Wilcoxon Test,
Figure 2B). VH usage also shifts as animals mature. Splenic B-1a cells from neonatal mice (2-–7 days)
preferentially express the V3 (36–60), V5 (7183) and V2 (Q52) families that are largely located proxi-
mal to D and J gene segments (Figure 3—figure supplement 1D), consistent with previous findings
that hybridomas derived from fetal/neonatal B cells are bias in expressing proximal V5 (7183) and V2
(Q52) family genes (Perlmutter et al., 1985). In contrast, the splenic B-1a cells from adult animal (2–
6 months) show higher frequencies in expressing distal V1 (J558) family genes including V1-75, V1-
64, V1-55 and V1-53 (Figure 3—figure supplement 1D).
Collectively, we conclude that the B-1a IgH repertoire integrates rearrangements from sequential
waves of de novo B-1a development that mainly occur during the first few weeks of life. The IgH rep-
ertoires defined during these waves are distinguishable both by N-additions at CDR3 junctions and
by VH gene usage.
Recurring V(D)J sequences increase with age in the pre-immune B-1a
IgH repertoire
Certain V(D)J nucleotide sequences become progressively more dominant with age in the B-1a rep-
ertoire. Thus, only a lower proportion of V(D)J sequences are detected at relative higher frequency
in the splenic B-1a IgH repertoire before 3 weeks, after which, both the number of recurrent sequen-
ces and the frequency at which each is represented increase progressively until the animals reach 4–
6 month of age (Figure 5A, Table 2). Consequently, the distribution of the splenic B-1a IgH CDR3
nucleotide sequences diversity is much less random in adults (2–6 months) than in neonates (2–7
days) (Figure 2A).
The recurrent V(D)J sequences include VH11-encoded PtC-binding V(D)J sequences, which are ini-
tially present at very low frequencies (2–6 days) but increase aggressively as animals mature to mid-
dle age (6 months) (Figure 5B). Since de novo B-1a development is minimum at adulthood, the
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progressive increase in the representation of the recurrent V(D)J sequences as animals reach adult-
hood suggests that B-1a cells are self-replenishing.
Certain V(D)J sequences are conserved by being positively selected
into the shared adult B-1a pre-immune IgH repertoire
To determine to what extent the IgH CDR3 sequences (amino acid and nucleotide) expressed by
each B cell subset are shared across different individuals, we carried out CDR3 sharing analysis. In
the B-1a IgH repertoire, overall, we found 30 such highly shared IgH CDR3 peptides, each of which
is expressed in over 80% of the splenic B-1a samples taken from more than 20 animals with nine dif-
ferent ages (from 2 days to 6 months) (Table 3). Each of the shared CDR3 peptides would be
expected to be encoded by several convergent V(D)J recombinations, i.e., distinct V(D)J rearrange-
ments encode the same CDR3 amino acid sequence (Venturi et al., 2008). Strikingly, we found that
each of the shared CDR3 peptides is encoded by an identical V(D)J nucleotide sequence in over
70% of splenic B-1a samples from adult animals (2-6 months, 9 mice) (Table 3).
These V(D)J nucleotide sequences represent the IgH structures that are positively selected into
the shared adult B-1a IgH repertoire among C57BL/6 mice. Although the specificities of the majority
of these selected V(D)J sequences remain to be defined, they include sequences that are specific for
PtC and sequence for the T15 idiotype B-1a anti-PC antibodies (Masmoudi et al., 1990). Of note,
most of these V(D)J sequences have nucleotide additions and/or deletions in the CDR3 junction
(Table 3), indicating that the driving force for the selection may include, but is certainly not
restricted to the germline rearrangement.
Figure 3. Comparison of VH gene usage by splenic B-1a vs MZB B cells. (A) VH gene usage profile shown as the percentage of IgH sequences
expressing the listed individual VH genes for individual B cell samples. The profiles are shown for adult splenic B-1a samples (n = 9, red) and for MZB
samples (n = 5, green). VH genes (from left to right) are ordered in 5’- to 3’-direction bases on chromosome location; the IMGT VH gene nomenclature
is used (Lefranc, 2003). (B) VH genes showing the statistically significant differences (Welch’s t-test p<0.05) between two groups are listed and also
highlighted with asterisks in the plot. To minimize the impact of the clonal expansion on the VH gene usage profile, data are presented as the
normalized distribution that counts each distinct CDR3 nucleotide sequence expressing a given VH gene as one, no matter how many times the
sequence was detected. Note: VH12-3 encoded IgH sequences are not detected in this study due to the technical limitations that exclude the VH12-3
primer from the set of primers designed about three years ago and used for studies presented here. We have since corrected this problem so that
VH12-3 primer is now part of our new set of primers. Comparison of sequence data obtained with old vs. the new set of primers shows that, aside from
now detecting VH12-3 sequences with the new set of primers, the sequences obtained with both primer sets are highly similar (Figure 3—figure
supplement 2).
DOI: 10.7554/eLife.09083.009
The following figure supplements are available for figure 3:
Figure supplement 1. VH gene usage profile pair-wise comparison of B cell groups.
DOI: 10.7554/eLife.09083.010
Figure supplement 2. Almost identical top 10 highly recurring CDR3 sequences are detected for splenic B-1a IgH libraries obtained either with the old
or new primer set.
DOI: 10.7554/eLife.09083.011
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Table 3. Certain V(D)J sequences are positively selected and conserved in adult B-1a pre-immune IgH repertoires.
CDR3 peptide
Predominant V(D)
J
CDR3 junction
diversity Representation in indicated repertoire
splenic B-1a
(2d-6M)
splenic B-1a (2-6M) addition deletion PerC B-1a (2W-
6M)
splenic
B-1a (4M
germ free)
FOB (2-
5M)
MZB (1-
5M)
1 TRWDY 17/
20
V6-6 J2 8/
9
TGG J2(8) 11/11 5/6 1/8 0/7
2 MRYSNYWYFDV 17/
20
V11-2 D2-6 J1 9/
9
0 0 11/11 6/6 1/8 1/7
3 MRYGNYWYFDV 18/
20
V11-2 D2-8 J1 9/
9
0 0 11/11 6/6 1/8 1/7
4 MRYGSSYWYFDV 17/
20
V11-2 D1-1 J1 9/
9
0 0 11/11 6/6 1/8 1/7
5 VRHYGSSYFDY 15/
20
V10-1 D1-1 J2 5/
9
0 J2(1) 11/11 3/6 0/8 0/7
6 ARHYYGSSYYFDY 19/
20
V5-6-1 D1-1
J2
9/
9
0 0 11/11 6/6 2/8 0/7
7 ARLDY 20/
20
V1-53 J2 7/
9
CTg/a J2(8) 10/11 4/6 0/8 1/7
8 ARDYYGSSYWYFDV 19/
20
V7-1 D1-1 J1 6/
9
0 V7-1(3) 9/11 5/6 1/8 1/7
9 ARDYYGSSWYFDV 19/
20
V1-26 D1-1 J1 7/
9
G J1(3) 2/11 4/6 0/8 1/7
10 ANWDY 19/
20
V14-3 D4-1 J2 6/
9
0 V14-3(2)J2
(8)
5/11 2/6 0/8 0/7
11 ATGTWFAY 18/
20
V1-19 D4-1 J3 5/
9
0 V1-19(2) 6/11 2/6 0/8 1/7
12 ARYYYGSSYAMDY 19/
20
V7-3 D1-1 J4 8/
9
0 V7-3(1)J4(4) 10/11 3/6 3/8 3/7
13 ARYSNYYAMDY 18/
20
V1-39 D2-6 J4 6/
9
0 J4(2) 8/11 1/6 0/8 0/7
14 ARDFDY 19/
20
V1-64 J2 6/
9
G J2(3) 1/11 3/6 1/8 1/7
15 ARYYSNYWYFDV 17/
20
V1-9 D2-6 J1 6/
9
0 0 4/11 1/6 0/8 0/7
16 ARYDYDYAMDY 17/
20
V1-39 D2-4 J4 6/
9
0 J4(3) 7/11 1/6 0/8 0/7
17 ARHYYGSSYWYFDV 18/
20
V2-6-2 D1-1
J1
6/
9
0 0 6/11 2/6 1/8 3/7
18 ARFYYYGSSYAMDY 19/
20
V1-55 D1-1 J4 6/
9
T J4(4) 8/11 3/6 1/8 1/7
19 ARWDFDY 19/
20
V1-7 J2 6/
9
TGGG J2(3) 1/11 3/6 1/8 1/7
20 ARGAY 19/
20
V1-80 J3 5/
9
GGG J3(8) 7/11 6/6 1/8 1/7
21 ARRFAY 18/
20
V1-26 J3 7/
9
C/A J3(8) 9/11 3/6 1/8 1/7
22 ARRDY 18/
20
V1-55 J2 5/
9
AGg/a J2(8) 6/11 3/6 1/8 1/7
23 ASYDGYYWYFDV 18/
20
V1-55 D2-9 J1 8/
9
CTATG V1-55(1) 9/11 5/6 0/8 0/7
24 ASYAMDY 16/
20
V7-3 J4 8/
9
0 V7-3(5)J4(4) 9/11 6/6 0/8 1/7
25 ARRYYFDY 17/
20
V1-78 J2 7/
9
CGg/cT 0 8/11 2/6 0/8 0/7
Table 3 continued on next page
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The majority of the V(D)J nucleotide sequences that are conserved in the splenic B-1a IgH reper-
toire are also conserved in the peritoneal B-1a IgH repertoires (2W-6M, 11 samples) (Table 3). Such
V(D)J nucleotide sequences, however, are rarely detectable in FOB and MZB IgH repertoires (1-5M,
7-8 samples), either because these cells do not express these CDR3 peptides or because they use
different V(D)J recombination sequences to encode them (Table 3). For example, although MZB
cells express antibodies encoding the same CDR3 peptide as B-1a T15-id+, they use different V(D)J
recombinations and no single V(D)J recombination dominates within the MZB IgH repertoire
(Table 4). In essence, the selection of a predominant V(D)J nucleotide sequence encoding a given
CDR3 peptide is unique for the B-1a IgH repertoire.
Multiple distinct V(D)J recombinations that encode the same CDR3
peptide in neonatal and young mice converge to a single identical V(D)J
sequence in all adults
In 2–7 day animals, a few selected V(D)J nucleotide sequences, such as PtC-binding sequences, have
already emerged as the predominant V(D)J recombination for their corresponding CDR3 peptide
(Figure 6A, pattern II). However, most of the selected V(D)J nucleotide sequences, including T15Id+,
do not initially represent the predominant recombination for their corresponding CDR3 peptide. In
particular, some CDR3 peptides are each encoded by multiple different V(D)J recombinations with
similar frequencies in neonate mice. However, after weaning, a particular V(D)J recombination grad-
ually increases its representation until it dominates in the adult B-1a IgH repertoire (Figure 6A, pat-
tern I). In essence, although multiple distinctive V(D)J recombinations encoding the same CDR3
peptide exist in the neonatal/young B-1a IgH repertoire, a single identical V(D)J recombination
sequence is selected to encode the particular CDR3 peptide in adult repertoire of almost all
individuals.
In accordance with this finding, quantification of the diversity of V(D)J recombination events for
each CDR3 peptide reveals the profound convergent recombination in the neonatal B-1a IgH reper-
toire. Thus, about 30% of CDR3 peptide sequences in splenic B-1a IgH repertoire at 2–6 day are
encoded by more than one V(D)J recombination (entropy >0.5, Figure 6B,C), and about 10% of
CDR3 peptide sequences show the highest level of convergent recombination (entropy >1.5,
Figure 6B,C, the higher the entropy value, the more diverse the V(D)J recombinations). However,
the frequency of CDR3 peptides showing convergent recombinations steadily decrease until the ani-
mals reach adulthood (2 months), after which very few (<1%) CDR3 peptide sequences show the
multiple V(D)J recombinations (entropy >1.5, Figure 6B,C).
The step-wise decreases in the level of convergent recombination as animals age indicate the
potent selection that over-time shapes the B-1a IgH repertoire. In most cases, the related V(D)J
Table 3 continued
CDR3 peptide
Predominant V(D)
J
CDR3 junction
diversity Representation in indicated repertoire
26 ARNYYYFDY 15/
20
V1-53 D1-2 J2 8/
9
t/a 0 10/11 2/6 0/8 0/7
27 ARYYGNYWYFDV 15/
20
V3-8 D2-8 J1 5/
9
0 0 5/11 2/6 0/8 0/7
28 ARRYYGSSYWYFDV 15/
20
V1-55 D1-1 J1 7/
9
CGG 0 10/11 5/6 1/8 1/7
29 ARRLDY 13/
20
V1-22 J2 7/
9
CGAC J2(6) 8/11 2/6 0/8 1/7
30 ARFAY 18/
20
V1-80 J3 4/
9
0 J3(4) 2/11 3/6 0/8 0/7
Column 1: CDR3 peptide sequences identified to be shared in >80% of splenic B-1a samples (20 samples from mice ranging from 2 day to 6 month
old); Column 2: for each shared CDR3 peptide, a single V(D)Jrearrangement sequence is selected and conserved in over 70% of adult B-1a samples (9
samples, 2-6 month old); Columns 3 and 4: nucleotides added or deleted in CDR3 junctions; Columns 5-8: the representation of each selected V(D)J
sequence within the indicate repertoires (age and number of samples are shown for each group). Rows 2-4 are PtC-binding CDR3 sequences; Row 8 is
CDR3 sequence for T15 Id+ anti-PC antibody. The data for germ-free animals is discussed at the end of the Result section.
DOI: 10.7554/eLife.09083.016
Yang et al. eLife 2015;4:e09083. DOI: 10.7554/eLife.09083 13 of 32
Research article Cell biology Immunology
sequences that ‘converge’ to encode the same CDR3 peptide share the same D and J segments but
use distinct VH genes (Figure 6—figure supplement 1). Therefore, despite encoding the same
CDR3 peptide sequence, these related V(D)J sequences differ in their upstream regions including
the CDR2 (Figure 6—figure supplement 1). These upstream differences, which can contribute to
ligand binding, may be central to the selection of the predominant V(D)J sequence for the corre-
sponding CDR3 peptide.
AID-mediated SHM in pre-immune B-1a IgVH initiates after weaning and
cumulatively increases the IgH repertoire diversity thereafter
Greater than 25% of splenic B-1a IgH sequences in 4–6 month old mice have at least one nucleotide
change (Figure 7A). Such mutations are principally mediated by AID because they are rare (<2%) in
splenic B-1a cells from age-matched AID-deficient mice (Figure 7A). The SHM even targets V(D)J
sequences that are positively selected into the shared B-1a IgH repertoire in wild type mice (but not
in AID-deficient mice) (Figure 7B,D). The observed mutations, most of which result in amino acid
changes, are largely targeted AID hotspots, i.e., DGYW (D = A/G/T; Y = C/T; W = A/T) or WRCH (R
= A/G, H = T/C/A) (Di Noia and Neuberger, 2007) (Figure 7B,C).
In contrast, mutations are minimal in IgVH of splenic FOB, MZB and peritoneal B-2 cells from adult
mice (Figure 7A). Interestingly, the frequency of mutated IgH sequences in peritoneal B-1a cells in
4-6 month old mice is substantially lower than that in age-matched splenic B-1a cells and mutations
are mainly single nucleotide change (Figure 7A).
Figure 4. N nucleotide insertion distribution patterns for the B-1a pre-immune IgH repertoires during ontogeny.
(A) Percentage of IgH sequences containing the indicated number of N nucleotide insertions at the IgH CDR3
junctions (V-DJ + D-J) is shown for each spleen B-1a sample from mice at indicated ages (shown at the right). To
minimize the impact of self-renewal on the N-addition profile, normalized data are presented. Thus, each distinct
IgH sequence containing indicated N nucleotide insertions is counted as one regardless how many times this
sequence was detected. Note that the N insertion pattern changes as animals age. Colors distinguish three age-
related patterns: green, D2 to D6; blue, D7 to 3W; red, 2M to 6M. (B) Percentages of IgH sequences containing
the indicated N-nucleotide insertions (shown at the top) for splenic B-1a samples at the indicated ages are shown.
Each dot represents data from an individual mouse, except for day 2 sample, n = 5-7.
DOI: 10.7554/eLife.09083.012
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SHM in splenic B-1a IgVH initiates after weaning and the frequency of mutated IgH transcripts
increases with age. Thus, mutations are minimally detectable in the IgVH of splenic B-1a cells from
neonates (2–7 days) and young mice (2–3 weeks), are at lower frequencies in 2 month old mice, and
are at substantially higher frequencies in 4–6 month old animals (Figure 7A). This age-dependent
increase in splenic B-1a IgVH mutation argues that the detected SHM is not due to contamination
with co-sorted B cells of other subsets, including GC cells, i.e., cells with the germinal center pheno-
type (GL7+ CD38lo CD95hi) are not detectable in the splenic B-1a population (Figure 7—figure sup-
plement 1).
Furthermore, SHM is cumulative, becoming more pronounced with age. Thus, roughly 25% of IgH
sequences from 4–6 month old splenic B-1a samples contain > = 1 nucleotide change, 19% contain
> = 2 changes, and 9% contain > = 4 changes (Figure 7A and Figure 7—figure supplement 2). This
translates to an average SHM rate of roughly 5 per 103 base pairs (bp) (Figure 7E), the similar range
as that for SHM in GC responses, i.e., 10-3 bp per generation (Wagner and Neuberger, 1996). Both
the frequency of mutated sequences and the mutation rate for splenic B-1a samples from 2 month
old mice are substantially lower than those in 4–6 month old mice (Figure 7A,E), further supporting
that the SHM in the splenic B-1a IgVH is an accumulative process.
Age-dependent progressive increase in the splenic B-1a IgVH mutations
is accompanied by increased class-switching
Class switch recombination (CSR) is another genetic alteration process that somatically diversifies
rearranged IgH genes. Both SHM and CSR are triggered by AID, which targets and introduces
lesions in the IgV region for SHM and the switch regions for CSR (Muramatsu et al., 2000;
Chaudhuri and Alt, 2004). Although both events require AID, SHM and CSR employ different
enzymes and thus can occur independently (Li et al., 2004). Nevertheless, since they usually occur at
Figure 5. Certain V(D)J sequences increase progressively with age in the B-1a pre-immune IgH repertoire. (A) IgH
CDR3 tree map plots for splenic B-1a samples from mice at different ages are shown. Each plot represents data
for an individual mouse, except for the day 2 sample. Recurrent sequences are visualized as larger contiguously-
colored rectangles in each plot. (B) Relative frequencies of three PtC-binding IgH CDR3 sequences in indicated
splenic B-1a sample groups (n = 5–8 for each group) are plotted with mouse age. Sequence information (peptide
and V(D)J recombination) is shown at the top.
DOI: 10.7554/eLife.09083.013
The following figure supplement is available for figure 5:
Figure supplement 1. The peritoneal B-1a IgH repertoire is increasingly restricted during ontogeny.
DOI: 10.7554/eLife.09083.014
Yang et al. eLife 2015;4:e09083. DOI: 10.7554/eLife.09083 15 of 32
Research article Cell biology Immunology
the same differentiation stage and both are initiated by AID, the question arises as to whether the
detected SHM in B-1a IgH is associated with CSR.
Our method allows detection of all different Ig isotypes. For each B cell sample, we quantified
the frequency of IgH sequences expressing a given isotype and examined the relationship between
the isotype profiles to the mutation status. Consistent with the close relationship between CSR and
SHM, wild-type B cell samples that have minimal IgVH mutations, including the splenic FOB, MZB,
peritoneal B-2, neonate splenic B-1a (2–7 days), young splenic and peritoneal B-1a (2–3 weeks),
rarely express class-switched transcripts (Table 5). Similarly, for B cell populations that show lower
levels of mutation, e.g., splenic B-1a from 2 month old animals and peritoneal B-1a from 2–6 month
old animals, the majority of both mutated and non-mutated sequences are either IgM or IgD and
thus rarely class-switched (Figure 8A, Table 5).
In contrast, both the mutated and non-mutated IgH sequences from splenic B-1a in 4–6 month
old animals contain class-switched Ig (Figure 8). Importantly, the class-switched Ig (mainly IgG3,
IgG2b, IgG2c and IgA) represents a significantly higher proportion of the mutated sequences than
of the non-mutated sequences (Figure 8A, Table 6), indicating that the increased SHM with age in
the splenic B-1a IgH repertoire is accompanied by increased class-switching. However, despite the
increased class switching among mutated sequences, the frequency of class-switched sequences
appears not to correlate with the increased number of mutations (Figure 8B). Consistent with the
class-switching dependence on AID, we did not detect isotypes other than IgM and IgD in splenic B-
1a cells from 4–5 month old AID-deficient mice (Table 5).
The splenic B-1a cells that express class-switched Ig still express IgM on the surface, since cells
were sorted as IgMhi IgDlo/- dump- CD19+ CD93- CD21-/lo CD23- CD43+ CD5+. In addition, IgM+
cells described here barely co-express other surface isotypes. Thus the class-switched transcripts are
derived from IgM+ cells that apparently have already undergone class switching but have yet to
turn off IgM surface protein expression. Since all of the cell preparation, staining and sorting were
performed equivalently for all samples, our finding that the class-switched transcripts were selec-
tively and predominantly detected in splenic B-1a cells from 4–6 month old mice argues that the
detection of these transcripts is not due to contamination or other technical problems.
The V(D)J selection and AID-mediated diversification that uniquely act
in B-1a IgH repertoire operate comparably in germ-free and
conventional mice
The microbiota are often thought to participate in shaping the repertoire of ‘natural’ antibodies,
which is largely produced by B-1a (Baumgarth et al., 2005). Nevertheless, we find that germ-free
(GF) animals have normal numbers of B-1a cells in spleen (Figure 9—figure supplement 1). Notably,
the splenic B-1a IgH repertoires in age-matched (4-5 month old) specific pathogen free (SPF) and GF
mice are very similar: 1) their IgH repertoires are comparably less diversified and enriched in the
recurrent V(D)J sequences (Figures 2A, 9A, Table 7); 2) their VH usage patterns show no significant
differences (Figure 3—figure supplement 1E); 3) their CDR3 peptide expressions show a compara-
ble extent of sharing between SPF and GF mice (Figure 9B); and 4) a substantial proportion of V(D)J
Table 4. MZB IgH repertoires use different V(D)J recombination sequences to encode the same
CDR3 peptide as that of B-1a anti-PC T15Id+.
MZB sample Id Age (Months) V(D)J recombination
7630 2 V1-76 D1-1 J1 and V1-39 D1-1 J1
10658 2 V1-76 D1-1 J1
8700 4 V1-72 D1-1 J1 and V8-12 D1-1 J1
8701 5 V1-58 D1-1 J1 and V1-61 D1-1 J1
13338 4 V1-61 D1-1 J1 and V5-16 D1-1 J1
Column 1: individual MZB samples tested; column 2: age of mouse for each MZB sample; column 3: for each MZB
sample, V(D)J recombination events that encode ARDYYGSSYWYFDV, which is the CDR3 peptide associated with
B-1a anti-PC T15Id+.
DOI: 10.7554/eLife.09083.017
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sequences selected in the B-1a IgH repertoire in adult SPF mice are similarly selected in the B-1a
IgH repertoire in GF mice (Table 3).
Further, hypermutation occurs equally in the splenic B-1a IgVH in 4–6 month old SPF and GF
mice, i.e., the frequency of mutated sequences and the mutation rate are comparable under two
conditions (Figure 7A,E). Indeed, AID introduces mutations into the identical V(D)J sequences
expressed by splenic B-1a cells from either SPF or GF mice (Figure 7B,C). Finally, similar to SPF
mice, AID-mediated class-switch occurs comparably in splenic B-1a cells from GF mice (Figure 8A).
Since the V(D)J selection, hypermutation and class-switching operate comparably in splenic B-1a
from GF and SPF mice, we conclude that the somatic mechanisms that select and diversify B-1a IgH
repertoire over time are not driven by microbiota-derived antigens.
Nevertheless, the environment has a strong impact on the isotype representation. IgA transcripts
are readily detected in splenic B-1a from 4–6 month old SPF mice; however, these transcripts are
minimally detected in the splenic B-1a from age-matched GF mice (Figure 8B, Table 6). This finding
is consistent with the recognition that class-switching to IgA is strongly associated with the presence
of gut microbiota (Kroese et al., 1989; Macpherson et al., 2000).
Discussion
Studies presented here open a new perspective on the origin and breadth of humoral immunity that
protect against invading pathogens and regulate autoimmunity. Recent studies have already shown
B-1a develops prior to and independent from BM HSC, which fail to generate B-1a but fully consti-
tute FOB and MZB compartment (Ghosn et al., 2012; Yoshimoto et al., 2011). Cohering the funda-
mental difference in their development origin, our studies reveal two distinct IgH repertoires that
develop at different times and are shaped by distinct functional mechanisms.
The first of these repertoires is expressed in B-1a cells. The de novo IgH rearrangements in this
repertoire occur mainly during the first few weeks of age and largely cease thereafter. Then B-1a
cells persist as a self-replenishing population. The B-1a repertoire, however, continues to evolve
under stringent selection. Thus, certain V(D)J sequences increase with age, and certain V(D)J nucleo-
tide sequences gradually emerge as the predominant recombinations encoding the specific CDR3
peptides in all adults. Furthermore, the age-dependent V(D)J selection coincides with the progres-
sive introduction of IgVH mutation and increased class-switch. Importantly, the V(D)J selection and
AID-mediated diversification occur comparably in germ-free and conventional mice, indicating that
these unique repertoire-defining mechanisms are not driven by microbiota-derived antigens.
In contrast, MZB, FOB and peritoneal B-2 cells develop later, and continuously develop de novo
from BM HSC throughout life and express drastically different IgH repertoire(s). Their IgH repertoires
tend to preferentially utilize V1 (J558) family, are far more diverse and less repetitive and, unlike B-
1a cells, show no apparent selection for particular V(D)J recombination sequences and do not show
IgVH mutation and class-switch. In essence, AID introduces SHM and CSR in these B cell subsets only
when they respond to their cognate antigens that are largely exogenous in nature.
These findings were enabled by employing the amplicon-rescued multiplex PCR technology,
which allows the capture and amplification of Ig transcripts from a given B cell population in an inclu-
sive and quantitative fashion. Specifically, the first RT-PCR reaction, which uses an array of gene-spe-
cific primers for almost all VH families and all constant (CH) genes, is carried out only for a few cycles.
The second round of PCR is then carried out with communal primers that recognize the unique
sequences tagged into each of the VH and CH primers. Since these ‘tag sequences’ were already
introduced during the initial cycles, the use of the communal primers assures that all of the targets
are amplified with reduced bias during the following exponential phase of amplification. Coupled
with the next generation sequencing, our method is quite robust and allows detection of diverse Ig
transcripts that collectively carry about 100 VH genes associated with different isotypes.
As with other bulk RNA sequence measurement, our methods cannot determine the absolute
number of each Ig transcript in a given B cell population. Hence the actual number of cells express-
ing a certain Ig sequence is unknown. In addition, our methods do not allow determination of
whether certain sequences associated with distinct isotypes belong to the same cell. Further, since
the Ig transcript copy number variation among cells is unknown, the frequency of a given Ig tran-
script is roughly viewed as the relative index of the frequency of cells expressing this Ig transcript.
This assumption is generally valid since our studies exclude plasmablast and plasma cells, which do
not express surface CD5. Since B-1a cells are well-known to undergo self-replenishment in adult, the
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dramatic increase in certain V(D)J sequences in the B-1a IgH repertoire over time likely reflects the
expansion of cells expressing this particular V(D)J sequence.
Single cell sequencing analysis has advantages in reducing technical bias and in enabling paired
IgH/IgL sequencing. Nevertheless, sequencing costs are still a big hurdle to the large-scale single
cell analysis, which, as our studies demonstrate, is necessary to develop a comprehensive view of the
various B cell subset repertoires. Therefore, at least for the present, our approaches are more effi-
cient and practical.
B-1a produce ‘natural’ antibodies, many of which recognize endogenous (self) antigens
(Baumgarth et al., 2005) and play house-keeping roles in clearing the cellular debris or metabolic
wastes (Shaw et al., 2000; Binder and Silverman, 2005). Since the natural antibodies can also
react/cross-react with microorganism-derived antigens, they also participate in the first line of
immune defense (Ochsenbein et al., 1999; Baumgarth et al., 2000). Germ-free mice have normal
levels of circulating ‘natural’ IgM (Bos et al., 1989). Earlier immunologists have postulated that the
natural antibody repertoire is selected by endogenous (self) antigens (Jerne, 1971; Coutinho et al.,
1995). Our studies, which demonstrate that B-1a IgH repertoire (hence the re-activities of natural
antibodies) is highly similar between individual adult C57BL/6 mice, regardless of whether the ani-
mals are reared in conventional or germ-free facilities, introduce the solid evidence supporting this
argument.
Our studies also demonstrate that the B-1a IgH repertoire is selected over time. Thus, recurrent V
(D)J sequences appear later, and most of the V(D)J sequences that are selected to be conserved in
all individuals do not emerge until the animals reach the adulthood. As a result, the sequence com-
position of B-1a IgH repertoire in adult mice becomes much less random than that expressed in neo-
nate and younger mice. Furthermore, the convergent selection of a particular V(D)J recombination
sequence encoding a specific CDR3 peptide indicates that the selection is strikingly precise and
occurs at both the protein and the nucleotide level.
Figure 6. The level of convergent recombination in the B-1a IgH repertoire declines with age. (A) Entropy heat map showing the diversity of V(D)J
recombination events for each indicated CDR3 peptide (shown at the left) in splenic B-1a samples at different ages (shown at the bottom). The higher
the entropy value, the more diverse the V(D)J recombinations for a given CDR3 peptide. CDR3 peptide sequences for T15 Id+ anti-PC (pattern I) and
anti-PtC (pattern II) antibody are shown in bold. (B) The diversities of the V(D)J recombination for each CDR3 peptide for the indicated splenic B-1a
samples (shown at the bottom) are quantified as entropy values (see Methods and materials), which are ranked into 4 ranges (shown at the right). For
each sample, the frequencies of CDR3 peptide sequences belonging to each entropy range are shown as stacks. (C) Splenic B-1a samples are grouped
based on age. For each group (n = 5–7), the frequencies of CDR3 peptide sequences belonging to each of four entropy ranges are shown. *p<0.05,
Welch’s t-test.
DOI: 10.7554/eLife.09083.018
The following figure supplement is available for figure 6:
Figure supplement 1. Distinct V(D)J sequences encoding the same CDR3 peptide differ in VH usage.
DOI: 10.7554/eLife.09083.019
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Table 5. B cell samples that show minimal or low level mutations in IgVH rarely express class-switched transcripts.
Sample Id subset age strain
non-mutated or
mutated
sequences (%)
IgM
(%) IgD (%)
IgG1
(%)
IgG3
(%)
IgG2c
(%)
IgG2b
(%) IgE (%) IgA (%)
13965 sB-1a 4M AIDKO non-
mutated
98.2 99.5 0.5
mutated 1.8 100
13968 sB-1a 5M AIDKO non-
mutated
99 100
mutated 1 100
13971 sB-1a 4M AIDKO non-
mutated
98.4 99.6 0.4
mutated 1.6 100
13972 sB-1a 4M AIDKO non-
mutated
100 99.9 0.1
8704 pB-1a 4M AIDKO non-
mutated
98.2 99.9 0.1
mutated 1.8 100
13973 pB-2 5M AIDKO non-
mutated
100 91.6 8.4
8700 MZB 5M WT non-
mutated
99.8 99.9 0.1
8701 MZB 4M WT non-
mutated
98.6 99.9 0.1
7630 MZB 2M WT non-
mutated
99.5 99.9 0.1
10658 MZB 2M WT non-
mutated
100 100
8702 FOB 5M WT non-
mutated
99.8 98.6 1.4
13966 FOB 3.5M WT non-
mutated
99.5 99.7 0.3
7631 FOB 2M WT non-
mutated
99.3 72.9 27.1
7629 pB-2 4M WT non-
mutated
98.4 88.4 11.5
mutated 1.6 89 11
13969 pB-2 3.5M WT non-
mutated
99.5 90.1 9.9
13974 sB-1a day 2 WT non-
mutated
99.2 99.8 0.2
13000 sB-1a day 2 WT non-
mutated
99.2 100
10659 sB-1a day 5 WT non-
mutated
99.2 100
9866 sB-1a day 5 WT non-
mutated
100 100
10651 sB-1a day 5 WT non-
mutated
99.7 100
10652 sB-1a day 6 WT non-
mutated
99.4 100
9868 sB-1a day 7 WT non-
mutated
99.3 99.9 0.1
9865 sB-1a day 7 WT non-
mutated
99.5 99.6 0.4
Table 5 continued on next page
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Table 5 continued
Sample Id subset age strain
non-mutated or
mutated
sequences (%)
IgM
(%) IgD (%)
IgG1
(%)
IgG3
(%)
IgG2c
(%)
IgG2b
(%) IgE (%) IgA (%)
11168 sB-1a 2W WT non-
mutated
99.1 99.9 0.1
13005 sB-1a 2W WT non-
mutated
99.5 100
10654 sB-1a 3W WT non-
mutated
95.8 100
mutated 4.2 100
11160 pB-1a 2W WT non-
mutated
99 100
10655 pB-1a 3W WT non-
mutated
99.2 100
11163 pB-1a 1M WT non-
mutated
99.1 99.9
7632 sB-1a 2M WT non-
mutated
88.1 99.1 0.9
mutated 11.9 99.9 0.1
10656 sB-1a 2M WT non-
mutated
88.1 99.8 0.2
mutated 11.9 100
13004 sB-1a 2M WT non-
mutated
97.7 99.9
mutated 2.3 94 6
13018 pB-1a 2M WT non-
mutated
91.8 100
mutated 8 100
13660 pB-1a 2M WT non-
mutated
92.2 100
mutated 7.6 100
7628 pB-1a 2M WT non-
mutated
92.3 99.5 0.4 0.1
mutated 7.1 99.6 0.2 0.2
8705 pB-1a 4M WT non-
mutated
93.8 99.7 0.3
mutated 4.4 99.9
9870 pB-1a 4M WT non-
mutated
86.4 99.9
mutated 12.6 99.9
11165 pB-1a 5M WT non-
mutated
98.1 99.9
mutated 1.5 100
8707 pB-1a 5M WT non-
mutated
91.6 97.2 0.1 2 0.5 0.1 0.1
mutated 6.2 97.9 0.1 2
9861 pB-1a 6M WT non-
mutated
82.4 99.6 0.4
mutated 17.5 100
Table lists each individual B cell sample (labeled as distinct Id number) from wild-type (WT) or AID-deficient (AIDKO) mice. The mouse age and sample
subset information are also shown. For each sample, the sequences are divided into non-mutated or mutated (> = 1 nucleotide change) categories, the
frequencies of each category are shown. For each category, the frequencies of sequences with each isotype are also shown.
DOI: 10.7554/eLife.09083.025
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Unexpectedly, our studies find that both SHM and CSR participate in diversifying the B-1a IgH
repertoire. However, unlike GC response SHM, which occurs within a few days following antigenic
stimulation, SHM in B-1a IgVH starts after weaning and is cumulative with age. The progressive
increase in the SHM is also associated with increased class switching. Most importantly, SHM and
CRS occur comparably in germ-free and conventional mice, indicating that SHM and CSR in the B-1a
primary IgH repertoire are not driven by microbiota-derived antigen. Since B-1a cells are well-known
to produce anti-self antibodies, stimulation by endogenous antigens is likely the major driving force
for the AID-mediated diversification processes.
Ongoing SHM in the absence of external antigens influence have been reported in sheep B cells
(Reynaud et al., 1995). The accumulation of SHM in B-1a IgVH over time likely represents a similar
strategy to further diversify their restricted Ig repertoire as animal age. Such diversification may
potentiate defenses against newly encountered pathogens. However, the age-dependent accumula-
tive SHM, which is likely driven by self-antigens, may also increase the risk of autoimmune disease
Table 6. Both the mutated and non-mutated IgH sequences obtained from splenic B-1a cells in 4-6 month old animals contain class-
switched Ig.
sample
Id subset age condition
non-mutated
or mutated
sequences (%) IgM (%) IgD (%)
IgG1
(%) IgG3 (%) IgG2c (%) IgG2b (%)
IgE
(%)
IgA
(%)
9867 sB-1a 6M SPF non-
mutated
50 95.8 2.7 0.6 0.8 0.1
mutated 50 65 0.03 16.8 4.3 4.8 9.1
8699 sB-1a 4M SPF non-
mutated
56 99.5 0.3 0.1 0.1
mutated 44 89.9 3.4 2 1.3 3.4
9863 sB-1a 4M SPF non-
mutated
74.1 93.9 0.2 3.6 1 1.3
mutated 25.9 44.2 41 9.7 3.7 1.4
13970 sB-1a 3.5M SPF non-
mutated
74.1 92.7 0.5 3.7 1.7 1.3
mutated 25.9 92.1 2.5 0.5 4.8 0.1
13342 sB-1a 4M SPF non-
mutated
88.9 97.6 0.5 0.8 0.6 0.2 0.3
mutated 11.1 85.2 0.3 0.2 7.3 7
13337 sB-1a 4M GF non-
mutated
69.7 98.5 0.1 0.8 0.4 0.1
mutated 30.3 79 15.3 5 0.7
13003 sB-1a 4M GF non-
mutated
74.8 97.2 0.3 0.2 0.5 0.2 1.6
mutated 25.2 89.8 1.1 2.3 1.2 5.6
13341 sB-1a 4M GF non-
mutated
78.2 99 0.1 0.2 0.1 0.6
mutated 21.8 72.2 9.6 5.5 12.6 0.1
13017 sB-1a 4M GF non-
mutated
80.9 95.6 0.4 2 1 1
mutated 19.1 79 0.2 7.9 3.9 8.9 0.1
13002 sB-1a 4M GF non-
mutated
88.5 97.4 0.5 0.6 0.2 1.3
mutated 11.5 63.8 14.8 8.4 13
Table lists individual splenic B-1a cell sample sorted from 4-6 month old C57BL6/J mice reared under either specific pathogen free (SPF) or germ-free
(GF) condition. For each sample, the sequences are divided into non-mutated or mutated (> = 1 nucleotide change) categories, the frequencies of each
category are shown. For each category, the frequencies of sequences expressing each isotype are shown. The data for germ-free animals is discussed
at the end of the result section.
DOI: 10.7554/eLife.09083.026
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Table 7. Top 10 highly recurring CDR3 sequences (peptide and V(D)J recombination) detected in
listed splenic B-1a samples from age-matched SPF and GF mice.
sB-1a samples (4 months)
Top 10 IgH CDR3 sequences
Peptide V(D)J
germ-free #1 1 MRYGSSYWYFDV V11-2 D1-1 J1
2 ARGAY V1-80 J2
3 ARNPDGYYTYYYAMDY V2-2 D2-9 J4
4 ARDPFYYYGSSYWYFDV V5-16 D1-1J1
5 MRYSNYWYFDV V11-2 D2-6 J1
6 AITRAY V1-55 J3
7 ARRYYGSSYWYFDV V1-55 D1-1 J1
8 ARSDYYGSSSLSY V1-26 D1-1 J2
9 ASGGNYFDY V1-75 J2
10 ARSLYN V1-9 J2
germ-free #2 1 ARNYGSSYDY V1-53 D1-1 J2
2 TRPSYYGSDY V14-4 D1-1 J2
3 TRESYDGYYVWYAMDY V5-9-1 D2-9 J4
4 ARGDY V14-3 J2
5 ASNWAY V1-53 D4-1 J2
6 MRYSNYWYFDV V11-2 D2-6 J1
7 AKGDYYGSSYYFDY V1-9 D1-1 J2
8 VRHGPRAFDY V10-1 D3-2 J2
9 ARLNGDY V1-69 J2
10 MRYGNYWYFDV V11-2 D2-8 J1
specific pathogen free #1 (from Caltech) 1 ASYSNSDV V3-6 D2-6 J1
2 ARVSYSRAMDY V14-3 D2-6 J4
3 ARSGNYGAMDY V1-7 D2-8 J4
4 ASRLRSTFAY V2-6-8 D1-1 J3
5 ARVTTVHAMDY V1-55 D1-1 J4
6 ARNYGSSYWYFDV V1-53 D1-1 J1
7 ARTPNWEARDY V1-55 D4-1 J4
8 ARRYYGSSYWYFDV V1-55 D1-1 J1
9 ARPLLYRYYFDY V1-75 D2-6 J2
10 ARNYGSSYDWYFDV V1-9 D1-1 J1
specific pathogen free #2 (from Caltech) 1 ARGGIYYDYDEVYYYAMDY V1-55 D2-4 J4
2 MRYSNYWYFDV V11-2 D2-6 J1
3 ARDYYGSSWYFDV V1-26 D1-1 J1
4 MRYGNYWYFDV V11-2 D2-8 J1
5 MRYGSSYWYFDV V11-2 D1-1 J1
6 ARYYDGYYGYYAMDY V1-26 D2-4 J4
7 ALITTWYFDV V1-78 D1-2 J1
8 ARHYYGSSWGY V1-53 D1-1 J2
9 ARSFSPYYFDY V1-26 J2
10 ARSHGYYPFDY V1-54 D2-9 J2
Table 7 continued on next page
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due to pathogenic high affinity auto-reactive antibodies. Indeed, deregulated B-1a growth have
been reported in NZB/W mice, where autoantibody-associated autoimmune disease develops as ani-
mal age (Hayakawa et al., 1984).
AID-mediated mutagenesis in B-1a IgVH may occasionally introduce mutations elsewhere in the
genome that facilitate dysregulated growth and neoplastic transformation, e.g., B-chronic lympho-
cytic leukemia (B-CLL) (Stall et al., 1988; Kipps et al., 1992; Phillips and Raveche, 1992). Although
the mechanism by which the IgM+ splenic B-1a cells from older mice express class-switched Ig tran-
scripts remains elusive, this finding suggests that certain cells are undergoing vigorous genetic alter-
ation that may share the similar mechanisms that underlie the malignant transformation. In fact, cells
with simultaneous expression IgM and class-switched Ig transcripts have been reported in B-CLL and
other B cell tumors (Oppezzo et al., 2002; Kinashi et al., 1987).
The splenic and peritoneal B-1a IgH repertoires show similar characteristics. Both repertoires
become more restricted with age with increased recurrent V(D)J sequences (Figure 5—figure sup-
plement 1) and retain the positive selected V(D)J sequences in adult animals. However, our studies
reveal the key repertoire differences between B-1a cells at their two native locations. Although both
repertoires show extensive CDR3 sharing among individual mice, the peritoneal B-1a IgH repertoire
is more similar to neonatal splenic B-1a repertoire and shows a significantly higher level of CDR3
peptide sharing among individual mice than the splenic B-1a repertoire (Figure 2B). In addition, the
peritoneal B-1a IgH repertoire is more biased in using V6-6 (J606), V9-3 (Vgam3.8), V2-9 (Q52) and
V2-6-8 (Q52), which are preferentially expressed in splenic B-1a from neonate and younger mice.
These findings suggest that peritoneal B-1a cells are enriched for cells that are generated during
neonatal and young age of life, thus are largely consist of cells migrated from spleen into PerC when
the animals were younger. This argument is further supported by the findings that the frequencies of
Table 7 continued
sB-1a samples (4 months)
Top 10 IgH CDR3 sequences
Peptide V(D)J
specific pathogen free #1 (from Stanford) 1 ARSADYGGYFDV V1-64 D2-4 J1
2 ARGAY V1-80 J2
3 ARSYYDYPWFAY V1-76 D2-4 J3
4 ARRWLLNAMDY V1-9 D2-9 J4
5 ARPYYYGSSPWFAY V1-69 D1-1 J3
6 ARNDYPYWYFDV V1-4 D2-4 J1
7 ARSGDY V1-64 J2
8 ARVIGDY V1-53 D2-14 J4
9 ARANY V1-55 J3
10 AVNWDYAMDY V1-84 D4-1 J4
specific pathogen free #2 (from Stanford) 1 ARGNY V1-80 J2
2 ARWVYYGSSSYWYFDV V1-54 D1-1 J1
3 ARSSNYAMDY V1-78 D2-11 J4
4 ARYYYGSNYAMDY V7-3 D1-1 J4
5 ARGAY V1-80 J2
6 ARRYYGSSYWYFDV V1-55 D1-1 J1
7 ARSPYYSNYEGYFDV V1-72 D2-6 J1
8 ARKNYGSSYWYFDV V1-55 D1-1 J1
9 ARLEIYYGNYGRVFDV V1-80 D2-8 J2
10 ARRDYYGSSYVLAY V1-9 D1-1 J3
Table lists the top 10 highly recurring CDR3 sequences (peptide and V(D)J recombination) shown in each of CDR3
tree-map plot (Figure 9A).
DOI: 10.7554/eLife.09083.029
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mutated sequences in the peritoneal B-1a cells from 4-6 month old mice are substantially lower and
Figure 7. AID-mediated SHM accumulates on splenic B-1a IgVH with age. (A) Percentages of sequences
containing > = 1 (red) or > = 2 (green) nucleotide changes for B cell samples from mice at the indicated ages are
shown (n = 3-8). Seven B cell samples from 4-5 month old AID knockout mice include sB-1a (n = 4), pB-1a (n = 1),
FOB (n = 1) and pB-2 (n = 1). Sequences with the identical V(D)J recombination encoding ARGAY CDR3 peptide
obtained from splenic B-1a sample from 4 month old specific pathogen free mouse, (B) germ-free mouse (C) and
AID knockout mouse (D) are listed. The nucleotide substitution is analyzed at the VH region stretching from the
start of CDR2 (red box) to the beginning of CDR3 (yellow box). Obtained sequence (upper line) is aligned with the
reference (lower line) for V1-80 (red), J3 (blue) and constant region of IgM isotype (orange). Mutations are
highlighted with triangles; asterisks indicate mutations resulting in an amino acid change; red and blue triangles
denote mutations in DGYW and WRCH motifs, respectively. (E) Numbers of mutations per 104 base pairs for
indicated B cell group are shown. Each dot represents data from an individual sample (n = 3–8). The data for
germ-free (GF) animals is discussed at the end of the Result section. Note: The mutation profiles for the splenic B-
1a IgH libraries prepared by using either old (VH12-3 deficient) or new primer set (VH12-3 included) are highly
similar (Figure 7—figure supplement 3).
DOI: 10.7554/eLife.09083.020
The following figure supplements are available for figure 7:
Figure supplement 1. Splenic B-1a cells do not contain cells expressing GC phenotype.
DOI: 10.7554/eLife.09083.021
Figure supplement 2. Percentage of sequences containing > = 4 nucleotides changes for each B cell group.
DOI: 10.7554/eLife.09083.022
Figure supplement 3. Identical V(D)J recombination sequences containing identical mutated nucleotides are
detected in sequence data sets for IgH libraries obtained by using either old or new primer set.
DOI: 10.7554/eLife.09083.023
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the mutations are mainly single nucleotide changes whereas a proportion of IgH sequences with
multiple mutations is detected in splenic B-1a cells from the same aged mice (Figure 7).
MZB and B-1a share many phenotypic and functional characteristics (Martin and Kearney,
2001). Our studies show that the MZB IgH repertoire differs drastically from the B-1a IgH repertoire,
but is very similar to the repertoires expressed by splenic FOB and peritoneal B-2. Since MZB and
FOB cells are mainly derived from BM HSC (Ghosn et al., 2012), there findings collectively support
the idea that these B cells belong to the same (i.e.,B-2) developmental lineage. Nevertheless, the
Figure 8. Progressive increase in the splenic B-1a IgVH mutation frequency with age is accompanied by increased
class-switching. (A) Left panel: The frequencies of non-mutated or mutated (> = 1 nucleotide substitution) IgH
sequences obtained from indicated B cell samples are shown; Right panel: The frequencies of sequences
expressing class-switched isotypes (neither IgM nor IgD) among non-mutated or mutated sequences are shown.
Each dot represents data from an individual sample (n = 5–6). p values are calculated based on the Nonparametric
Wilcoxon test. (B) In each plot, the IgH sequences obtained from each splenic B-1a sample from 3.5–6 month old
mice are divided into five categories, based on the number of mutated nucleotides (0, 1, 2, 3, 4, > = 5) per read.
In each plot, the values shown at the top are the frequencies of sequences in each category. For each category of
sequences, frequencies of the distinct isotype sequences are shown as stacks. A = IgA; D = IgD; G = IgG1 + IgG3
+ IgG2c + IgG2b. Each plot represents the data for a splenic B-1a sample from an individual mouse reared under
either specific pathogen free (SPF) (upper plots) or germ-free (GF) (lower plots) conditions. The data for germ-free
(GF) animals is discussed at the end of the Result section.
DOI: 10.7554/eLife.09083.024
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MZB repertoires from individual mice contain substantially higher levels of common CDR3 sequences
(peptides) than the splenic FOB and peritoneal B-2 repertoires (Figure 2B).
Years ago, we postulated that B-1a and B-2 B cells belong to distinct developmental lineages
that are evolved sequentially to play complementary roles in immunity (Herzenberg and Herzen-
berg, 1989). The sequence data presented here, which reveal the key distinctions in the repertoires
as well as the repertoire-defining mechanisms between B-1a and B-2 subsets, support this argument
and greatly extend our earlier version. These key distinctions provide the genetic bases for their
well-known fundamental functional difference between B-1a and other B subsets. In particular, they
are central to vaccine development, where the recognition that the B cells have distinct targeting
antibody repertoires clearly invites attention. In addition, our findings offer insights in understanding
the origins and behaviors of B cell neoplasms, particularly B-CLL, and the autoimmune diseases in
which over production of autoantibodies is implicated in the pathology.
Figure 9. The B-1a IgH repertoires from mice raised in specific pathogen free condition are comparable to the B-
1a IgH repertoire from age-matched germ-free mice. (A) IgH CDR3 tree map plots for splenic B-1a cells from GF
mice (upper panel), or SPF mice in Caltech animal facility (middle panel), or SPF mice in Stanford animal facility
(bottom panel). Each plot represents the data for a sample from a 4 month old mouse. Recurrent CDR3
(nucleotide) sequences are visualized as larger contiguously-colored rectangles in each plot. (B) CDR3 peptide
pair-wise sharing analysis of IgH repertoire similarity between multiple splenic B-1a samples from age-matched GF
and SPF mice. GF mice (n = 6); SPF mice (n = 6). CDR3 peptide pair-wise analysis was conducted between GF
mice (GF/GF), SPF mice (SPF/SPF) and GF vs. SPF mice (GF/SPF). Each dot represents the percentage of shared
CDR3 peptide sequences between two mice. There was no statistical difference between each comparison.
DOI: 10.7554/eLife.09083.027
The following figure supplement is available for figure 9:
Figure supplement 1. Normal splenic B-1a compartment in GF mice.
DOI: 10.7554/eLife.09083.028
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Materials and methods
Mice
C57BL/6J mice were purchased from the Jackson Laboratory. AID-deficient C57BL6/J mice were
kindly provided by Dr. Michel Nussenzweig (Rockefeller University). Mice were breed and kept in the
Herzenberg laboratory colony under SPF conditions at the Stanford Veterinary Service Center (VSC).
Spleens from germ-free C57BL6/J mice were provided by Dr. Sarkis Mazmanian (Caltech). Germ-
free mice were maintained in sterile Trexler isolators and fed autoclaved food and water. Germ-free
status was assayed monthly by aerobic and anaerobic plating; and by 16s rRNA PCR. Study proto-
cols were approved by the Stanford VSC.
Hi-dimensional FACS sorting
FACS staining has been previously described (Yang et al., 2012). Briefly, cell suspensions were incu-
bated with LIVE/DEAD Aqua (Life Technologies, San Diego, CA), washed, and incubated with uncon-
jugated anti-CD16/CD32 (FcRII/III) mAb to block Fc-receptors. Cells were then stained on ice for 20
min. with a ‘cocktail’ of fluorochrome-conjugated antibodies including: anti-CD21-FITC (Becton Dick-
enson, San Jose, CA), anti-CD43-PE (BD), anti-CD5-PE-Cy5 (BD), anti-CD19-PE-Cy5.5 (Life Technolo-
gies), anti-CD93 (AA41)-PE-Cy7 (eBioscience, San Diego, CA), anti-B220-APC (BD), anti-IgM-
Alexa700 (Herzenberg lab), anti-IgD-APC-Cy7 (BioLegend, San Diego, CA), anti-CD23-Biotin (BD),
anti-CD11b-PB (Life Technologies), anti-Gr-1-PB (Life Technologies), anti-TCRab-PB(Life Technolo-
gies), anti-CD11c-PB (Life Technologies), and anti-CD3?-PB (Life Technologies). After washing, cells
were stained with Streptavidin-Qdot 605 (Life Technologies). Cells were sorted on FACS Aria (BD) at
the Stanford Shared FACS Facility. Sorting purity was greater than 99%. Five types of B cell popula-
tions were sorted based on tissue and phenotype: splenic and peritoneal B-1a cells (dump- CD19+
CD93- IgMhi IgD-/lo CD21-/lo CD23- CD43+ CD5+); splenic FOB and peritoneal B-2 cells (dump-
CD19+ CD93- IgMlo IgDhi CD23+ CD43- CD5-); splenic MZB cells (dump- CD19+ CD93- IgMhi IgD-/lo
CD21hi CD23lo/- CD43- CD5-). 1-2 x 104 cells for each cell population were sorted directly into
0.5 mL Trizol LS (Life Technologies).
Amplicon rescued multiplex PCR
RNA was extracted according to the protocol provided by Trizol LS (Life Technologies). RT-PCR
reactions were conducted using a set of sequence specific primers covering almost all of mouse VH
genes (forward primers) and constant CH primers covering all of isotypes (reverse primers). Illumina
paired-end sequencing communal primer B is linked to each forward VH primer. Illumina paired-end
sequencing communal primer A and a barcode sequence of 6 nucleotides are linked to each reverse
CH primers. In brief, cDNA was reverse transcribed from total RNA sample using mixture of forward
VH and reverse CH primers and reagents from the OneStep RT-PCR kit (Qiagen, Valencia, CA). The
first round of PCR was performed at: 50˚C, 40 minutes; 95˚C, 15 min; 94˚C, 30 s, 58˚C, 2 min, 72˚C,
30 s, for 15 cycles; 94˚C, 30 s, 72˚C, 2 min, for 10 cycles; 72˚C, 10 min. After the first round of PCR,
primers were removed by Exonuclease I digestion at 37˚C for 30 min (New England Biolabs, lpswich,
MA). Then 2 mL of the first-round PCR products were used as templates for the second round of
amplification using communal A and B primers and reagents from the Multiplex PCR kit (Qiagen).
The second round PCR was performed as: 95˚C, 15 min; 94˚C, 30 s, 55˚C, 30 s, 72˚C, 30 s, for 40
cycles; 72˚C, 5 min. About 400bp long PCR products were run on 2% agarose gels and purified
using a gel extraction kit (Qiagen). The IgH libraries were pooled and sequenced with Illumina MiSeq
pair-end read-length platform. The output of IgH sequence covers CDR2, CDR3 and the beginning
of the constant region. The sequence information for all primers used for the library preparation can
be found in US Patent Office (US9012148).
Sequence analysis
Sequence reads were de-multiplexed according to barcode sequences at the 5’ end of reads from
the IgH constant region. Reads were then trimmed according to their base qualities with a 2-base
sliding window, if either quality value in this window is lower than 20, this sequence stretches from
the window to 3’ end were trimmed out from the original read. Trimmed pair-end reads were joined
together through overlapping alignment with a modified Needleman-Wunsch algorithm. If paired
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forward and reverse reads in the overlapping region were not perfectly matched, both forward and
reverse reads were thrown out without further consideration. The merged reads were mapped using
a Smith-Waterman algorithm to germline V, D, J and C reference sequences downloaded from the
IMGT web site (Lefranc, 2003). To define the CDR3 region, the position of CDR3 boundaries of ref-
erence sequences from the IMGT database were migrated onto reads through mapping results and
the resulting CDR3 regions were extracted and translated into amino acids.
Artifacts removal
C57BL/6J mouse VH reference sequences were pair-wise aligned with a Smith-Waterman algorithm.
Two VH reference sequences are considered related if the aligned region between them is > 200bp
matched and < 6 mismatches. Two sequence reads were considered related if the best mapped VH
sequences are related and the CDR3 segments have less than 1 mismatch. If two sequences are
related and the frequency of the minor one is less than 5% of the dominant one, the minor one is
removed from further consideration. In addition, single copy CDR3s are removed from further
consideration.
To allow multiplexing of multiple samples in a single sequence run, CH primers were linked with
barcodes containing 6 different nucleotides. The barcode CH primers were used in a first round RT-
PCR. To compensate for potential in chemical synthetic, PCR and/or sequencing error, barcodes were
designed with a Hamming distance 3. Given that the chemical synthetic error is roughly 5% per posi-
tion, there is about a 1/8000 chance that one barcode is mistakenly synthesized as another barcode.
For a CDR3 with n occurrences in one sample and the same CDR3 (nucleotide sequence) with N occur-
rences in another sample in the same sequencing run, we calculated the probability that such a CDR3
would occur n or more times if it were due to cross-contamination, using the following formula
P ¼ 1  
Pn 1
k¼1
e l  lk
k! where l is the expected number of errors given N reads and is computed by
l ¼ N   and m is the cross-contamination rate which is preset as 1/8000. CDR3s that yielded
p<0.001 were considered highly unlikely to be due to cross-contamination. Sequences were obtained
for 60 separately sorted cell populations (details for each population are in Table 1).
CDR3 tree map analysis
To draw the IgH CDR3 tree-map for each sequence sample, the entire rectangle was divided: 1st into a
set of rectangles with each rectangle corresponding to a distinct VH gene segment; 2
nd into a set of V-
J rectangles with each rectangle corresponding to a distinct V-J; and 3rd into a set of V-J-CDR3 rectan-
gles with each rectangle representing a distinct V-J-CDR3 combination. The rectangles are ordered
based on area from largest at the bottom right to smallest at the top left. The size of an individual rect-
angle is proportional to the relative frequency for each V-J-CDR3 combination sequence. In order to
distinguish neighboring rectangles, corners of each rectangle are rounded and each rectangles are
colored randomly. Therefore, each rectangle drawn in the map represents an individual CDR3 nucleo-
tide sequence.
CDR3 sequence diversity (D50) measurement
D50 is a measurement of the diversity of an immune repertoire of J individuals (total number of
CDR3s) composed of S distinct CDR3s in a ranked dominance configuration, where r1 is the abun-
dance of the most abundant CDR3, r2 is the abundance of the second most abundant CDR3, and so
on. C is the minimum number of distinct CDR3s with > = 50% total sequencing reads. D50 is given
by
Assume that r1  r2     ri     riþ1     rs|ﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄ{zﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄﬄ}
s
;
Xs
i¼1
ri ¼ J
if
Xc
i¼1
ri  J=2 and
XC 1
i¼1
ri < J=2
D50 ¼
C
S
 100
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Mutation analysis
The forward VH primers used to amplify expressed IgH genes are located at the IgH framework
region 2. To avoid primers interfering with the mutation analysis, the variable region stretching from
the beginning of the CDR2 to the beginning to the CDR3 was examined for mismatches between
the sequence read and the best-aligned germline reference sequence. To eliminate the impact of
sequencing error on this calculation, only sequence reads with more than 4 copies were included in
the mutation calculation.
Quantification of the diversities of V(D)J recombination events for a
given CDR3 peptide
For this measurement, we introduce an entropy value as the index of diversity level. Assuming a dis-
tinct CDR3 peptide sequence X in a sample is derived from n number of distinct V(D)J recombina-
tions (nucleotide) with each frequency as P1, P2, . . . Pn respectively, the entropy for X (Ex) is then
calculated as: Ex ¼  
Pn
i¼1
Pi log2 Pi.
For a sample, after computing entropy values for each distinct peptide CDR3 fragments, the E
values for distinct peptide CDR3 fragments are categorized into four ranges: [0, 0.5), [0.5, 1.5), [1.5,
2.5) and [2.5, + ¥). The higher the entropy value, the more diverse the V(D)J recombinations for a
given CDR3 peptide.
Acknowledgements
We acknowledge Megan Phillips, Jeffrey Waters, Jasmine Sosa, John Mantovani and the Stanford
Shared FACS Facility for excellent assistance. We are grateful to Dr. Michel Nussenzweig (Rockefel-
ler University) for generously providing Aid-/- mice. Studies are supported by the US National Insti-
tutes of Health Grants R01-AI1076434 (LAH), R01-DK078938 (SKM) and by the HudsonAlpha
Institute for Biotechnology and iRepertoire (HJ).
Additional information
Competing interests
CW, JH: Co-founder of iRepertoire. The other authors declare that no competing interests exists.
Funding
Funder Grant reference number Author
National Institutes of Health R01-Al1076434 Leonore A Herzenberg
National Institutes of R01-DK078938 Sarkis K Mazmanian
The funders had no role in study design, data collection and interpretation, or the decision to
submit the work for publication.
Author contributions
YY, CW, JH, LAH, Conception and design, Acquisition of data, Analysis and interpretation of data,
Drafting or revising the article; QY, EEBG, Acquisition of data, Analysis and interpretation of data,
Drafting or revising the article; ABK, Conception and design, Analysis and interpretation of data,
Drafting or revising the article; HC, Acquisition of data, Drafting or revising the article, Contributed
unpublished essential data or reagents; GQ, Acquisition of data, Analysis and interpretation of data;
SKM, Analysis and interpretation of data, Drafting or revising the article, Contributed unpublished
essential data or reagents
References
Barber CL, Montecino-Rodriguez E, Dorshkind K. 2011. Reduced production of B-1-specified common lymphoid
progenitors results in diminished potential of adult marrow to generate B-1 cells. Proceedings of the National
Academy of Sciences 108:13700–13704. doi: 10.1073/pnas.1107172108
Yang et al. eLife 2015;4:e09083. DOI: 10.7554/eLife.09083 29 of 32
Research article Cell biology Immunology
Baumgarth N, Herman OC, Jager GC, Brown LE, Herzenberg LA, Chen J. 2000. B-1 and B-2 cell-derived
immunoglobulin m antibodies are nonredundant components of the protective response to influenza virus
infection. The Journal of Experimental Medicine 192:271–280. doi: 10.1016/S1074-7613(00)80418-5
Baumgarth N, Tung JW, Herzenberg LA. 2005. Inherent specificities in natural antibodies: a key to immune
defense against pathogen invasion. Springer Seminars in Immunopathology 26:347–362. doi: 10.1007/s00281-
004-0182-2
Baumgarth N. 2011. The double life of a B-1 cell: self-reactivity selects for protective effector functions. Nature
Reviews. Immunology 11:34–46. doi: 10.1038/nri2901
Binder CJ, Silverman GJ. 2005. Natural antibodies and the autoimmunity of atherosclerosis. Springer Seminars in
Immunopathology 26:385–404. doi: 10.1007/s00281-004-0185-z
Bogue M, Gilfillan S, Benoist C, Mathis D. 1992. Regulation of n-region diversity in antigen receptors through
thymocyte differentiation and thymus ontogeny. Proceedings of the National Academy of Sciences 89:11011–
11015. doi: 10.1073/pnas.89.22.11011
Bos NA, Kimura H, Meeuwsen CG, de Visser H, Hazenberg MP, Wostmann BS, Pleasants JR, Benner R, Marcus
DM. 1989. Serum immunoglobulin levels and naturally occurring antibodies against carbohydrate antigens in
germ-free BALB/c mice fed chemically defined ultrafiltered diet. European Journal of Immunology 19:2335–
2339. doi: 10.1002/eji.1830191223
Carlsson L, Holmberg D. 1990. Genetic basis of the neonatal antibody repertoire: germline V-gene expression
and limited N-region diversity. International Immunology 2:639–643. doi: 10.1093/intimm/2.7.639
Chaudhuri J, Alt FW. 2004. Class-switch recombination: interplay of transcription, DNA deamination and DNA
repair. Nature Reviews. Immunology 4:541–552. doi: 10.1038/nri1395
Coutinho A, Kazatchkine MD, Avrameas S. 1995. Natural autoantibodies. Current Opinion in Immunology 7:812–
818. doi: 10.1016/0952-7915(95)80053-0
di Noia JM, Neuberger MS. 2007. Molecular mechanisms of antibody somatic hypermutation. Annual Review of
Biochemistry 76:1–22. doi: 10.1146/annurev.biochem.76.061705.090740
Feeney AJ. 1990. Lack of n regions in fetal and neonatal mouse immunoglobulin v-d-j junctional sequences. The
Journal of Experimental Medicine 172:1377–1390. doi: 10.1084/jem.172.5.1377
Ghosn EEB, Yamamoto R, Hamanaka S, Yang Y, Herzenberg LA, Nakauchi H, Herzenberg LA. 2012. Distinct B-
cell lineage commitment distinguishes adult bone marrow hematopoietic stem cells. Proceedings of the
National Academy of Sciences 109:5394–5398. doi: 10.1073/pnas.1121632109
Gilfillan S, Dierich A, Lemeur M, Benoist C, Mathis D. 1993. Mice lacking TdT: mature animals with an immature
lymphocyte repertoire. Science 261:1175–1178. doi: 10.1126/science.8356452
Gitlin AD, Shulman Z, Nussenzweig MC. 2014. Clonal selection in the germinal centre by regulated proliferation
and hypermutation. Nature 509:637–640. doi: 10.1038/nature13300
Gu H, Fo¨rster I, Rajewsky K. 1990. Sequence homologies, n sequence insertion and JH gene utilization in VHDJH
joining: implications for the joining mechanism and the ontogenetic timing of Ly1 b cell and b-CLL progenitor
generation. The EMBO Journal 9:2133–2140.
Hardy RR, Carmack CE, Shinton SA, Riblet RJ, Hayakawa K. 1989. A single VH gene is utilized predominantly in
anti-BrMRBC hybridomas derived from purified Ly-1 B cells. definition of the VH11 family. Journal of
Immunology 142:3643–3651.
Hardy RR, Hayakawa K. 2001. B cell development pathways. Annual Review of Immunology 19:595–621. doi: 10.
1146/annurev.immunol.19.1.595
Hayakawa K, Hardy RR, Herzenberg LA, Herzenberg LA. 1985. Progenitors for Ly-1 B cells are distinct from
progenitors for other b cells. The Journal of Experimental Medicine 161:1554–1568. doi: 10.1084/jem.161.6.
1554
Hayakawa K, Hardy RR, Honda M, Herzenberg LA, Steinberg AD, Herzenberg LA. 1984. Ly-1 b cells: functionally
distinct lymphocytes that secrete IgM autoantibodies. Proceedings of the National Academy of Sciences 81:
2494–2498. doi: 10.1073/pnas.81.8.2494
Herzenberg LA, Herzenberg LA. 1989. Toward a layered immune system. Cell 59:953–954. doi: 10.1016/0092-
8674(89)90748-4
Holodick NE, Vizconde T, Rothstein TL. 2014. B-1a cell diversity: nontemplated addition in B-1a cell ig is
determined by progenitor population and developmental location. Journal of Immunology 192:2432–2441.
doi: 10.4049/jimmunol.1300247
Jerne NK. 1971. The somatic generation of immune recognition. European Journal of Immunology 1:1–9. doi:
10.1002/eji.1830010102
Kantor AB, Herzenberg LA. 1993. Origin of murine B cell lineages. Annual Review of Immunology 11:501–538.
doi: 10.1146/annurev.iy.11.040193.002441
Kantor AB, Merrill CE, Herzenberg LA, Hillson JL. 1997. An unbiased analysis of V(H)-D-J(H) sequences from B-
1a, B-1b, and conventional B cells. Journal of Immunology 158:1175–1186.
Kantor AB, Stall AM, Adams S, Herzenberg LA, Herzenberg LA. 1992. Differential development of progenitor
activity for three B-cell lineages. Proceedings of the National Academy of Sciences 89:3320–3324. doi: 10.
1073/pnas.89.8.3320
Kantor AB, Stall AM, Adams S, Watanabe K, Herzenberg LA. 1995. De novo development and self-
replenishment of B cells. International Immunology 7:55–68. doi: 10.1093/intimm/7.1.55
Kinashi T, Godal T, Noma Y, Ling NR, Yaoita Y, Honjo T. 1987. Human neoplastic B cells express more than two
isotypes of immunoglobulins without deletion of heavy-chain constant-region genes. Genes & Development 1:
465–470. doi: 10.1101/gad.1.5.465
Yang et al. eLife 2015;4:e09083. DOI: 10.7554/eLife.09083 30 of 32
Research article Cell biology Immunology
Kipps TJ, Rassenti LZ, Duffy S, Johnson T, Kobayashi RYO, Carson DA. 1992. Immunoglobulin v gene expression
in CD5 B-cell malignanciesa. Annals of the New York Academy of Sciences 651:373–383. doi: 10.1111/j.1749-
6632.1992.tb24638.x
Kirkham PM, Schroeder HW. 1994. Antibody structure and the evolution of immunoglobulin V-gene segments.
Seminars in Immunology 6:347–360. doi: 10.1006/smim.1994.1045
Kroese FG, Butcher EC, Stall AM, Lalor PA, Adams S, Herzenberg LA. 1989. Many of the IgA producing plasma
cells in murine gut are derived from self-replenishing precursors in the peritoneal cavity. International
Immunology 1:75–84. doi: 10.1093/intimm/1.1.75
Lalor PA, Stall AM, Adams S, Herzenberg LA. 1989. Permanent alteration of the murine Ly-1 B repertoire due to
selective depletion of Ly-1 B cells in neonatal animals. European Journal of Immunology 19:501–506. doi: 10.
1002/eji.1830190314
Lefranc M-P. 2003. IMGT, the international ImMunoGeneTics database. Nucleic Acids Research 31:307–310. doi:
10.1093/nar/gkg085
Li Z, Woo CJ, Iglesias-Ussel MD, Ronai D, Scharff MD. 2004. The generation of antibody diversity through
somatic hypermutation and class switch recombination. Genes & Development 18:1–11. doi: 10.1101/gad.
1161904
Macpherson AJ, Gatto D, Sainsbury E, Harriman GR, Hengartner H, Zinkernagel RM. 2000. A primitive T cell-
independent mechanism of intestinal mucosal IgA responses to commensal bacteria. Science 288:2222–2226.
doi: 10.1126/science.288.5474.2222
Malynn BA, Yancopoulos GD, Barth JE, Bona CA, Alt FW. 1990. Biased expression of JH-proximal VH genes
occurs in the newly generated repertoire of neonatal and adult mice. The Journal of Experimental Medicine
171:843–859. doi: 10.1084/jem.171.3.843
Martin F, Kearney JF. 2001. B1 cells: similarities and differences with other B cell subsets. Current Opinion in
Immunology 13:195–201. doi: 10.1016/S0952-7915(00)00204-1
Masmoudi H, Mota-Santos T, Huetz F, Coutinho A, Cazenave PA. 1990. All T15 Id-positive antibodies (but not
the majority of VHT15+ antibodies) are produced by peritoneal CD5+ B lymphocytes. International
Immunology 2:515–520. doi: 10.1093/intimm/2.6.515
Mercolino TJ, Arnold LW, Hawkins LA, Haughton G. 1988. Normal mouse peritoneum contains a large
population of Ly-1+ (cD5) B cells that recognize phosphatidyl choline. relationship to cells that secrete
hemolytic antibody specific for autologous erythrocytes. The Journal of Experimental Medicine 168:687–698.
doi: 10.1084/jem.168.2.687
Montecino-Rodriguez E, Leathers H, Dorshkind K. 2006. Identification of a B-1 B cell-specified progenitor.
Nature Immunology 7:293–301. doi: 10.1038/ni1301
Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y, Honjo T. 2000. Class switch recombination and
hypermutation require activation-induced cytidine deaminase (aID), a potential RNA editing enzyme. Cell 102:
553–563. doi: 10.1016/S0092-8674(00)00078-7
Ochsenbein AF, Fehr T, Lutz C, Suter M, Brombacher F, Hengartner H, Zinkernagel RM. 1999. Control of early
viral and bacterial distribution and disease by natural antibodies. Science 286:2156–2159. doi: 10.1126/
science.286.5447.2156
Oppezzo P, Magnac C, Bianchi S, Vuillier F, Tiscornia A, Dumas G, Payelle-Brogard B, Ajchenbaum-Cymbalista F,
Dighiero G, Pritsch O. 2002. Do CLL B cells correspond to naive or memory B-lymphocytes? evidence for an
active Ig switch unrelated to phenotype expression and Ig mutational pattern in B-CLL cells. Leukemia 16:
2438–2446. doi: 10.1038/sj.leu.2402731
Perlmutter RM, Kearney JF, Chang SP, Hood LE. 1985. Developmentally controlled expression of
immunoglobulin VH genes. Science 227:1597–1601. doi: 10.1126/science.3975629
Phillips J, Raveche´ E. 1992. Immunoregulatory capability of murine CLL-like CD5+ B cells. Annals of the New
York Academy of Sciences 651:488–490. doi: 10.1111/j.1749-6632.1992.tb24654.x
Rajewsky K. 1996. Clonal selection and learning in the antibody system. Nature 381:751–758. doi: 10.1038/
381751a0
Reynaud CA, Garcia C, Hein WR, Weill JC. 1995. Hypermutation generating the sheep immunoglobulin
repertoire is an antigen-independent process. Cell 80:115–125. doi: 10.1016/0092-8674(95)90456-5
Seidl KJ, Mackenzie JD, Wang D, Kantor AB, Kabat EA, Herzenberg LA, Herzenberg LA. 1997. Frequent
occurrence of identical heavy and light chain ig rearrangements. International Immunology 9:689–702. doi: 10.
1093/intimm/9.5.689
Shaw PX, Ho¨rkko¨ S, Chang MK, Curtiss LK, Palinski W, Silverman GJ, Witztum JL. 2000. Natural antibodies with
the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. The Journal of
Clinical Investigation 105:1731–1740. doi: 10.1172/JCI8472
Stall AM, Farinas MC, Tarlinton DM, Lalor PA, Herzenberg LA, Strober S, Herzenberg LA. 1988. Ly-1 B-cell
clones similar to human chronic lymphocytic leukemias routinely develop in older normal mice and young
autoimmune (New zealand black-related) animals. Proceedings of the National Academy of Sciences 85:7312–
7316. doi: 10.1073/pnas.85.19.7312
Tornberg UC, Holmberg D. 1995. B-1a, B-1b and B-2 B cells display unique VHDJH repertoires formed at
different stages of ontogeny and under different selection pressures. The EMBO Journal 14:1680–1689.
Venturi V, Price DA, Douek DC, Davenport MP. 2008. The molecular basis for public T-cell responses? Nature
Reviews. Immunology 8:231–238. doi: 10.1038/nri2260
Victora GD, Nussenzweig MC. 2012. Germinal centers. Annual Review of Immunology 30:429–457. doi: 10.1146/
annurev-immunol-020711-075032
Yang et al. eLife 2015;4:e09083. DOI: 10.7554/eLife.09083 31 of 32
Research article Cell biology Immunology
Wagner SD, Neuberger MS. 1996. Somatic hypermutation of immunoglobulin genes. Annual Review of
Immunology 14:441–457. doi: 10.1146/annurev.immunol.14.1.441
Xu JL, Davis MM. 2000. Diversity in the CDR3 region of V(H) is sufficient for most antibody specificities. Immunity
13:37–45. doi: 10.1016/S1074-7613(00)00006-6
Yancopoulos GD, Alt FW. 1986. Regulation of the assembly and expression of variable-region genes. Annual
Review of Immunology 4:339–368. doi: 10.1146/annurev.iy.04.040186.002011
Yang Y, Ghosn EEB, Cole LE, Obukhanych TV, Sadate-Ngatchou P, Vogel SN, Herzenberg LA, Herzenberg LA.
2012. Antigen-specific memory in B-1a and its relationship to natural immunity. Proceedings of the National
Academy of Sciences 109:5388–5393. doi: 10.1073/pnas.1121627109
Yoshimoto M, Montecino-Rodriguez E, Ferkowicz MJ, Porayette P, Shelley WC, Conway SJ, Dorshkind K, Yoder
MC. 2011. Embryonic day 9 yolk sac and intra-embryonic hemogenic endothelium independently generate a B-
1 and marginal zone progenitor lacking B-2 potential. Proceedings of the National Academy of Sciences 108:
1468–1473. doi: 10.1073/pnas.1015841108
Yang et al. eLife 2015;4:e09083. DOI: 10.7554/eLife.09083 32 of 32
Research article Cell biology Immunology
